fluorodeoxyglucose f18 has been researched along with Lymphoma, Large B-Cell, Diffuse in 530 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.19) | 18.2507 |
| 2000's | 53 (10.00) | 29.6817 |
| 2010's | 302 (56.98) | 24.3611 |
| 2020's | 174 (32.83) | 2.80 |
| Authors | Studies |
|---|---|
| Arens, AIJ; Boellaard, R; Burggraaff, CN; Celik, F; Chamuleau, MED; de Jong, D; de Keizer, B; de Vet, HCW; Eertink, JJ; Hoekstra, OS; Huijbregts, JE; Lugtenburg, PJ; Stroobants, S; Wiegers, SE; Zijlstra, JM; Zwezerijnen, GJC | 1 |
| Amit, O; Avivi, I; Bar-On, Y; Beyar-Katz, O; Cohen, D; Even-Sapir, E; Gold, R; Hazut Krauthammer, S; Luttwak, E; Perry, C; Ram, R | 1 |
| Maghfoor, I; Osmani, AH | 1 |
| Chen, Y; Liu, J; Xu, L; Yu, X | 1 |
| Fadzilah, H; Mahayuddin, AM; Siti Maisarah, MN | 1 |
| Casadei, B; Fanti, S; Farolfi, A; Garibotto, V; Paccagnella, A; Zinzani, P | 1 |
| Khan, MK; Mourad, WF | 1 |
| Plastaras, JP; Svoboda, J | 1 |
| Ahn, SS; Batchelor, TT; Chai Jung, S; Gon Choi, C; Guenette, JP; Han, K; Hong Choi, S; Hoon Kim, J; Huang, RY; Hyun Suh, C; Joon Kim, S; Kim, HS; Lee, SK; Min Lee, S; Nayak, L; Park, JE; Seong, M; Tae Kim, S | 1 |
| Kurokawa, M; Masamoto, Y | 1 |
| Chen, MT; Fan, W; Hu, YY; Jiang, YL; Li, YH; Tang, S; Xiao, ZZ; Zhang, X; Zhao, YM | 1 |
| Chan, JY; Chang, EW; Chiang, J; Farid H Rashid, M; Khoo, LP; Lam, WW; Lee, CY; Lim, ST; Ng, DZ; Poon, EY; Somasundaram, N; Tan, SH; Tan, YH; Tao, M; Tong, AK; Yang, VS | 1 |
| Arens, AIJ; Boellaard, R; Burggraaff, CN; de Keizer, B; de Vet, HCW; Eertink, JJ; Heymans, MW; Hoekstra, OS; Lugtenburg, PJ; Pieplenbosch, S; van der Holt, B; Wiegers, SE; Zijlstra, JM | 1 |
| Ali, F; McLeod, A; Schierz, JH | 1 |
| Benjamin, R; Cuadrado, M; Kayani, I; Kirkwood, AA; Kuhnl, A; Marzolini, MAV; Menne, T; Mulholland, N; O'Reilly, M; Osborne, W; Patten, PEM; Petrides, GS; Potter, V; Roddie, C; Sanderson, R; Townsend, W; Voo, S; Yallop, D | 1 |
| Becher-Boveleth, N; Bockisch, A; Broecker-Preuss, M; Dührsen, U; Grafe, H; Hanoun, C; Hüttmann, A; Klapper, W; Müller, SP; Rekowski, J; Richter, J | 1 |
| Bruno, A; Cascione, L; Ceriani, L; Chauvie, S; Dalmasso, F; Dirnhofer, S; Esposito, F; Giovanella, L; Gritti, G; Hayoz, S; Mamot, C; Milan, L; Pirosa, MC; Rambaldi, A; Schär, S; Zucca, E | 1 |
| Bordeau, K; Deshayes, E; Eberlé, MC; Fabbro, M; Fersing, C | 1 |
| Cortés-Romera, M; Gràcia-Sánchez, L; Muñoz-Palomar, A; Pudis, M; Sánchez-Rodríguez, IE | 1 |
| Kizaki, M; Momose, S; Tabayashi, T; Takayanagi, N; Tamaru, JI; Tanaka, Y; Tokuhira, M | 1 |
| Ichimaru, K; Matsuura, A; Nakata, J; Nakatsuka, SI; Shibano, M; Yasuhara, Y | 1 |
| Asmar, A; Fjordside, L; Mens, H | 1 |
| Bento-Miranda, M; Figueiredo, P; Gravito-Soares, E; Gravito-Soares, M; João, M | 1 |
| Ahn, JS; Ahn, SY; Jung, SH; Kim, HJ; Kim, M; Lee, JH; Lee, JJ; Shin, MG; Song, GY; Song, SY; Yang, DH | 1 |
| Cao, J; Hong, X; Ji, D; Jiang, J; Liu, L; Liu, X; Liu, Y; Lv, F; Song, S; Wang, Z; Xia, Z; Yu, B; Zhang, Q | 1 |
| Chen, L; Huang, Z; Tao, Y; Wang, F | 1 |
| Shen, G; Sun, H; Zhang, W | 1 |
| Cheah, CY; El-Galaly, TC; Gormsen, LC; Villa, D | 1 |
| Abgral, R; Berthou, C; Guillerm, G; Ianotto, JC; LE Roux, PY; Lombion, N; Robin, P; Salaün, PY; Schick, U; Tempescul, A | 1 |
| Chen, J; Ding, C; Huang, X; Jiang, C; Li, A; Teng, Y; Xu, J; Zhou, Z | 2 |
| Ahmed, DAT; Al Kandari, F; Hamadah, A; Usmani, S | 1 |
| Chen, K; Ding, C; Gao, Y; He, J; He, K; Jiang, C; Teng, Y; Wu, J; Zhang, J; Zhou, Z | 1 |
| Boellard, R; Bogsrud, T; Eikenes, L; Evensen, BV; Fagerli, UM; Giskeødegård, GF; Husby, T; Hustad, KV; Johansen, H | 1 |
| Baloğlu, MC; Beyhan, E; Çermik, TF; Erol Fenercioğlu, Ö; Şahin, R | 1 |
| Liu, Y | 1 |
| Ciarmiello, A; Ferrando, O; Giovacchini, G; Giovannini, E; Pastorino, S; Tutino, F | 1 |
| Barrington, SF; Boellaard, R; Ceriani, L; de Vet, HCW; Dührsen, U; Eertink, JJ; Heymans, MW; Hoekstra, OS; Hüttmann, A; Lugtenburg, PJ; Mikhaeel, NG; Schmitz, C; Wiegers, SE; Zijlstra, JM; Zucca, E; Zwezerijnen, GJC | 1 |
| Bastianello, M; Casale, G; Corradini, H; Gette, G; Konowalik, B; Manzur, T; Nagle, C; Riveros, D; Valda, A | 1 |
| Cao, J; Gu, JJ; Guo, Y; Hong, X; Ji, D; Jin, J; Liu, Y; Lv, F; Xia, Z; Xue, K; Zhang, Q | 1 |
| Lin, N; Ma, X; Xie, H; Zhang, W | 1 |
| Nakatani, K; Notohara, K; Saito, K; Sakata, E; Ueda, Y | 1 |
| Matsue, K; Narita, K; Suzuki, T | 1 |
| Bengtsson, T; Carano, RAD; de Crespigny, A; El-Galaly, TC; Hutchings, M; Jemaa, S; Kostakoglu, L; Nielsen, TG; Paulson, JN; Tracy, S; Trotman, J | 1 |
| He, Y; Huang, X; Li, B; Qian, D; Shi, Q; Wang, L; Yuan, C; Zhao, W | 1 |
| Li, J; Li, X; Shi, D; Tian, T; Wei, P; Yu, B; Zeng, Y; Zhou, X | 1 |
| Ahmed, S; Bogoni, G; Carneiro-Ramos, MS; Carvalho, MK; Castanheira de Souza, NF; Cen, P; Champlin, R; Cherng, HJ; Clark, AH; Dağ, İ; Djawad, K; Ertaş, S; Fayad, L; Feng, L; Ferri, D; Flowers, CR; Gonca Okumuş, Z; González-Lafuente, L; Gu, W; Hagemeister, F; He, Q; Imaizumi, U; Imura, M; Jiang, H; Junho, CVC; Kagawa, K; Kaneko, D; Kebriaei, P; Kido, K; Kishimoto, N; Kröcher, O; Kurata, S; Kuroda, H; Lee, HJ; Liu, XH; Lucas Júnior, RM; Ma, L; Macapinlac, HA; Massi, MN; Miskad, UA; Nachtegaal, M; Nair, R; Nastoupil, LJ; Navarro-García, JA; Neelapu, SS; Neres-Santos, RS; Nieto, Y; Patellongi, IJ; Pinnix, CC; Ramdial, J; Reis Schneider, GA; Rezvani, K; Rodriguez, M; Rodríguez-Sánchez, E; Ruiz-Hurtado, G; Rusinovich, V; Rusinovich, Y; Safonova, OV; Sanuki, T; Shi, JB; Shpall, E; Srour, S; Steiner, R; Strati, P; Sudagidan, M; Tian, M; Tsukimoto, S; Turhan, U; Ünver, G; Vidal, JE; Wang, M; Wang, YM; Westin, J; Wu, L; Xiao, Y; Xu, G; Xu, Y; Yan, YY; Yegin, Z; Yılmaz, S; Yu, K; Yusuf, I; Zabilska, A; Zhang, H; Zhang, Q; Zhang, X; Zhang, XX | 1 |
| Alentorn, A; Hernandez-Verdin, I; Hoang-Xuan, K; Houillier, C; Morales-Martinez, A; Nichelli, L | 1 |
| Byun, BH; Choi, CW; Choi, JH; Kang, HJ; Kim, BI; Lim, I; Lim, SM; Shin, DY | 1 |
| Nair, CK; Narayanan, AV; Nayanar, SK; Vijayakumar, G | 1 |
| Chen, SR; Cheng, ZZ; Jiang, X; Jiang, XM; Kou, Y; Peng, XJ; Yao, YT; You, JH; Yu, SS; Zhang, ZH | 1 |
| Ahmad, W; Asghar, N; Hassan, A | 1 |
| Chang, Y; Li, F; Sun, Y; Wang, N; Wang, R; Zhu, H | 1 |
| Akin, EA; Jacene, HA; Merryman, RW; Zeman, MN | 1 |
| Alessi, A; Argiroffi, G; Bagnoli, F; Carniti, C; Chiappella, A; Corradini, P; Dodero, A; Guidetti, A; Lorenzoni, A; Marasco, V; Monfrini, C; Pennisi, M; Pizzamiglio, S; Seregni, E; Verderio, P | 1 |
| Cui, Y; Deng, X; Fan, W; Jiang, Y; Li, Y; Liu, B; Long, W; Zhang, X | 1 |
| Bal, A; Kaur, G; Krishnaraju, VS; Kumar, R; Mittal, BR; Pandey, S; Prakash, G; Rana, N; Shukla, J; Singh, H; Sood, A | 1 |
| Bai, S; Guan, Y; Hao, Y; Liu, J; Shao, H; Xin, M; Zhang, C | 1 |
| Bartenstein, P; Blumenberg, V; Bücklein, VL; Dekorsy, FJ; Kunz, WG; Rejeski, K; Ricke, J; Ruzicka, M; Schmidt, C; Subklewe, M; Unterrainer, M; von Bergwelt-Baildon, M; Winkelmann, M | 1 |
| Chen, YH; Liu, SH; Lue, KH; Wu, YF | 1 |
| Jiang, Z; Li, M; Li, W; Liu, W; Wang, K; Yao, H; Zhang, L; Zhang, P; Zhao, S | 1 |
| Ahlström, H; Enblad, G; Essand, M; Gammelgård, G; Korenyushkin, A; Kullberg, J; Loskog, A; Lövgren, T; Sarén, T; Sjöholm, T | 1 |
| Baillet, C; Bailliez, A; Delaby, G; Dujardin, S; Huglo, D; Karimdjee, M; Willaume, A | 1 |
| Deng, Y; He, L; Xie, H; Zhang, W | 1 |
| Borte, G; Denecke, T; Franke, GN; Georgi, TW; Herling, M; Hoffmann, S; Jentzsch, M; Kluge, R; Kurch, L; Merz, M; Metzeler, K; Perez-Fernandez, C; Petermann, N; Platzbecker, U; Sabri, O; Schwind, S; Vučinić, V | 1 |
| Chang, CC; Chen, CH; Hsieh, JG; Jeng, JH | 1 |
| Auewarakul, CU; Carr, R; Cerci, JJ; Czibor, S; Fanti, S; Györke, T; Paez, D; Redondo, F | 1 |
| Hatano, K; Ishibashi, K; Ishii, K; Iwata, A; Kondo, S | 1 |
| Bartlett, NL; Friedberg, JW; Higley, HR; Kahl, BS; Kelloff, G; Knopp, MV; Leonard, JP; Pederson, LD; Poon, D; Ruppert, AS; Schöder, H; Schwartz, LH; Torka, P; Wilson, WH; Zhang, J | 1 |
| Bai, Y; Ding, Q; Jiang, X; Ju, H; Li, P; Lin, X; Wang, L; Wang, S | 1 |
| Botta, F; Ceci, F; Derenzini, E; Ferrari, ME; Fiori, S; Granata, C; Jereczek-Fossa, BA; Lo Presti, G; Mazzara, S; Melle, F; Motta, G; Pileri, S; Radice, T; Raimondi, S; Ramadan, S; Tabanelli, V; Tarella, C; Travaini, L; Vanazzi, A | 1 |
| Qiao, W; Sun, N; Wang, T; Xing, Y; Zhao, J | 1 |
| Ehman, EC; Homb, AC; Johnson, GB; Kemp, BJ; Mugu, VK; Nathan, MA; Packard, AT; Thanarajasingam, G; Young, JR | 1 |
| Fujita, K; Hara, T; Lee, S; Morishita, T; Negoro, E; Oiwa, K; Tsujikawa, T; Tsurumi, H; Ueda, T; Yamauchi, T | 1 |
| Barrington, SF; Boellaard, R; Ceriani, L; Chamuleau, MED; Czibor, S; de Vet, HCW; Dührsen, U; Eertink, JJ; Györke, T; Hanoun, C; Heymans, MW; Hoekstra, OS; Hüttmann, A; Kurch, L; Lugtenburg, PJ; Mikhaeel, NG; Pieplenbosch, S; Wiegers, SE; Zijlstra, JM; Zucca, E; Zwezerijnen, GJC | 1 |
| Bressel, M; Brown, R; Campbell, BA; Dickinson, M; Hofman, MS; Lambertini, A; MacManus, M; Seymour, JF; Wirth, A | 1 |
| Guan, M; Huang, J; Liu, M; Liu, W; Xie, P | 1 |
| Li, W; Ma, J; Sun, Y; Wang, Z; Xiao, S; Xu, H; Yang, G; Zhao, H | 1 |
| Aissat, A; Benmaad, I; Blanc-Durand, P; Claudel, A; Copie-Bergman, C; Delfau-Larue, MH; Gaulard, P; Gricourt, G; Haioun, C; Itti, E; Lafont, C; Le Goff, E; Lemonnier, F; Loyaux, R; MBoumbae, DL; Poullot, E; Robe, C; Roulin, L | 1 |
| Procházka, V | 1 |
| Carlsen, SS; Hansen, DL; Hersby, DS; Jelicic, J; Juul-Jensen, K; Kannik, K; Larsen, TS; Munksgaard, ASE; Thorsgaard, M | 1 |
| Aizawa, T; Handa, K; Hashimoto, K; Onoki, T; Suzuki, M; Takahashi, K; Watanabe, M | 1 |
| Li, B; Li, Z; Liu, C; Shi, P | 1 |
| Dai, N; Deng, S; Han, J; Huang, H; Jia, T; Sang, S; Zhang, B; Zhou, Y | 1 |
| Ahmed, N; Atanackovic, D; Bukhari, A; Chen, W; Dahiya, S; Dureja, R; Goloubeva, O; Gryaznov, A; Hardy, NM; Kim, DW; Kocoglu, MH; Kowatli, A; Law, JY; Lee, ST; Lutfi, F; Margiotta, P; Matsumoto, LR; McGuirk, JP; Mushtaq, MU; Rapoport, AP; Yared, JA | 1 |
| Chong, E; Schuster, SJ; Sun, C; Tong, Y; Torigian, DA; Udupa, JK; Winchell, N; Zou, Y | 1 |
| Chen, Y; Lin, Y; Miao, W; Wu, Z; Zheng, S | 1 |
| He, X; Jin, C; Liu, Y; Qian, W; Tian, M; Wang, J; Xu, C; Xue, C; Zhang, H; Zhang, L; Zhang, X; Zhao, S; Zhong, Y; Zhou, R; Zhou, Y | 1 |
| Gerke, O; Hildebrandt, MG; Juul-Jensen, K; Larsen, TS; Møller, MB; Nielsen, AL; Nielsen, NB | 1 |
| Alig, S; Alizadeh, AA; de Jong, D; Dührsen, U; Dürig, J; Hanoun, C; Hüttmann, A; Johansson, P; Klapper, W; Rekowski, J; Richter, J; Ylstra, B | 1 |
| Ding, C; Jiang, C; Jiang, Z; Lai, R; Ni, X; Qian, C; Sun, Y; Teng, Y; Tian, R; Xu, Y | 1 |
| Bin, J; Lu, L | 1 |
| Bailly, S; Chaouki, A; Gheysens, O; Krug, B; Roelants, V | 1 |
| Cao, Y; Cui, S; Gu, W; He, B; Liu, Y; Lu, L; Shao, X; Wang, F; Wang, J; Wang, Y; Yan, F; Yue, Y | 1 |
| Leung, JMS; Ng, KS | 1 |
| Katsuki, NE; Tago, M; Tokushima, M; Yamashita, SI | 1 |
| Chung, MJ; Eom, KY; Kim, JH; Kim, WC; Lee, JH; Lee, JW; Oh, D | 1 |
| Fukumi, T; Ishikawa, T; Makita, M; Moriyama, T; Murakami, H; Nagakita, K; Shinno, Y; Sunami, K; Yoshioka, T | 1 |
| Lund-Iversen, M; Skeie, AT; Switlyk, MD; Østenstad, B | 1 |
| Su, M; Wang, D; Xiao, J | 1 |
| Loi, HY; Sabiq, S; Sinha, AK; Tham, WY | 1 |
| Devillers, A; Girard, A; Haumont, LA; Lamy, T; Le Jeune, F; Mesbah, H; Palard-Novello, X; Pontoizeau, C; Salaün, PY; Tempescul, A | 1 |
| Erdil, TY; Filizoglu, N; Ones, T; Ozguven, S; Turoglu, HT | 1 |
| Liang, Z; Lu, J; Rong, R; Song, T; Su, Y | 1 |
| Çizmecioğlu, HA; Kaya, B; Şahin, Ö; Şen, AE; Serdengeçti, M | 1 |
| Cho, BS; Cho, SG; Eom, KS; Jeon, YW; Kim, DW; Kim, HJ; Kim, YJ; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, GJ; Park, SS; Shin, SH; Yahng, SA; Yoon, JH | 1 |
| Dong, P; Hu, W; Tian, B; Wang, L | 1 |
| Ishii, K; Kaida, H; Kimura, M; Kumode, T | 1 |
| Gupta, N; Singh, N | 1 |
| Baillet, C; Besson, A; Delaby, G; Herbaux, C; Hubaut, MA; Huglo, D; Morschhauser, F | 1 |
| Liu, J; Wang, W; Yang, J | 1 |
| Dejust, S; Durot, E; Grange, F; Morland, D; Papathanassiou, D | 1 |
| Bartlett, NL; Cheson, BD; Friedberg, JW; Hall, N; Higley, HR; Hsi, ED; Kahl, BS; Kelloff, G; Knopp, MV; Kostakoglu, L; Leonard, JP; Liu, H; Polley, MC; Schöder, H; Schwartz, LH; Wagner-Johnston, N; Wilson, WH; Zelenetz, AD; Zhang, J | 1 |
| Aide, N; Fruchart, C; Gac, AC; Lasnon, C; Nganoa, C | 1 |
| Araf, S; Barrington, SF; Bewicke-Copley, F; Cogliatti, S; Davies, A; Fehr, M; Fitzgibbon, J; Forrer, F; Graham, TA; Johnson, P; Korfi, K; Kumar, E; Okosun, J; Rimsza, LM; Scott, DW; Wang, J | 1 |
| Ainouche, A; Durot, C; Hoeffel, C; Morland, D; Papathanassiou, D | 1 |
| Bar-Shalom, R; Ganzel, C; Godefroy, J; Goldschmidt, N; Nachmias, B; Rozenbach, E; Vainstein, V | 1 |
| Li, L; Li, T; Liu, G; Zhu, L | 1 |
| Hashimoto, D; Hirata, K; Itoh, K; Izumiyama, K; Kanaya, M; Minauchi, K; Mori, A; Ota, S; Senjo, H; Teshima, T; Tsukamoto, E | 1 |
| Angrilli, F; D'Angelo, C; Mattoli, MV; Pennese, E; Taralli, S; Villano, C | 1 |
| Gallamini, A; Meignan, M | 1 |
| Aoyama, Y; Fukuzawa, T; Hashimoto, J; Ichikawa, T; Ikoma, H; Kajiwara, H; Kazama, T; Kodama, E; Kuroki, T; Mabuchi, T; Mikami, T; Nagafuji, Y; Nagao, R; Sekiguchi, Y | 1 |
| Dağlıöz Görür, G; Gedük, A; Mehtap, Ö; Ünal, S | 1 |
| Ardeshna, KM; Barrington, SF; Clifton-Hadley, L; Counsell, N; Cunningham, D; Lawrie, A; McMillan, A; Mikhaeel, NG; O'Doherty, MJ; Radford, JA; Smith, P | 1 |
| Buteau, JP; Hofman, MS; Seymour, JF | 1 |
| Cheng, X; Huo, L; Li, F; Wang, P | 1 |
| Kang, L; Su, T; Wang, H; Wang, S; Yang, L | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Lee, KH; Lim, CH; Moon, SH | 1 |
| Gabata, T; Goi, T; Higuchi, S; Hosono, N; Ikeno, H; Kimura, H; Koneri, K; Kosaka, N; Ozaki, K | 1 |
| Ding, CY; Fan, L; Li, JY; Wang, L; Xu, W; Zheng, XQ; Zhu, HY; Zou, YX | 1 |
| Kunz, WG; Rejeski, K; Ricke, J; Rudelius, M; Ruzicka, M; Schmidt, C; Subklewe, M; Unterrainer, M; Winkelmann, M | 1 |
| Fatima, N; Tahseen, R; Zaman, A; Zaman, MU; Zaman, S; Zaman, U | 1 |
| Aquino-Parsons, C; Bénard, F; Brown, MJ; Connors, JM; Farinha, P; Freeman, CL; Gerrie, AS; Lo, A; Morris, J; Pickles, T; Savage, KJ; Scott, DW; Sehn, LH; Skinnider, B; Slack, GW; Srour, L; Tonseth, P; Villa, DR; Wilson, DC | 1 |
| Pan, Z; Yu, T; Zhao, P | 1 |
| Farahmandfar, F; Moradian, S; Sadeghi, R; Shahlaei, S; Shakeri, S | 1 |
| Annunziata, S; Cuccaro, A; Giordano, A; Hohaus, S; Maiolo, E; Pelliccioni, A | 1 |
| Fujii, T; Hasebe, S; Miyagawa, M; Sugawara, Y; Takeuchi, K; Tanaka, K; Yakushijin, Y; Yamanaka, S | 1 |
| Berriolo-Riedinger, A; Blanc-Durand, P; Bodet-Milin, C; Carlier, T; Casasnovas, RO; Itti, E; Jégou, S; Kanoun, S; Kraeber-Bodéré, F; Le Gouill, S; Meignan, M | 1 |
| Bold, MS; Call, TG; Chanan-Khan, AA; Ding, W; Fonder, AL; Hanson, CA; Hayman, SR; Kay, NE; Kenderian, SS; Koehler, AB; Leis, JF; Muchtar, E; Parikh, SA; Rabe, KG; Schwager, SM; Shi, M; Slager, SL; Van Dyke, DL; Wang, Y | 1 |
| Chang, Y; Fu, X; Li, L; Li, X; Li, Z; Nan, F; Sun, Z; Tian, L; Wang, X; Wu, J; Wu, X; Xie, X; Yan, J; Yu, H; Zhang, L; Zhang, M; Zhang, X; Zhou, Z | 1 |
| Bengel, FM; Beutel, G; David, S; Derlin, T; Eder, M; Ganser, A; Koenecke, C; Möhn, N; Ross, TL; Schultze-Florey, C; Skripuletz, T; Werner, RA | 1 |
| Dührsen, U; Georgi, TW; Hasenclever, D; Hüttmann, A; Kluge, R; Kurch, L; Rekowski, J; Sabri, O; Schmitz, C | 1 |
| Buvat, I; Capobianco, N; Casasnovas, O; Chartier, L; Clerc, J; Cottereau, AS; Meignan, M; Nioche, C; Thieblemont, C; Vercellino, L | 1 |
| Allmer, C; Cerhan, JR; Habermann, TM; Harper, L; Higgins, A; Johnston, P; Kim, H; Maurer, MJ; Nowakowski, GS; Thanarajasingam, G; Thompson, CA; Witzig, TE; Young, JR | 1 |
| Barrington, SF; Trotman, J | 1 |
| Liu, Y; Miao, F; Yan, Q; Yu, J; Zhao, X | 1 |
| Audard, V; Dauvergne, M; El Karoui, K; Hammoud, M; Joher, N; Maarek, A; Mulé, S | 1 |
| Mikhaeel, NG; Wirth, A | 1 |
| Burton, C; Frangi, AF; Frood, R; Gleeson, F; Patel, C; Scarsbrook, A; Tsoumpas, C | 1 |
| Goldstein, J; Leonard, JP; Luan, D; Martin, P; Rutherford, S; Wu, Y | 1 |
| Chen, P; Huang, S; Lin, J; Liu, L; Yang, Y | 1 |
| Dong, XB; Ge, Y; Huo, Z; Li, TS; Wang, Q; Zhang, T | 1 |
| Gao, XD; Jiang, XF; Li, B; Liu, MK; Wang, L; Xie, W; Zhao, WL | 1 |
| Cheng, S; Dong, L; Guo, R; Jiang, X; Li, B; Qian, Y; Qin, W; Shen, R; Shi, Q; Wang, L; Xu, P; You, J; Zhao, W | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Lee, KH; Lim, CH | 1 |
| Tang, P; Tian, R; Wang, R | 1 |
| Barrington, SF; de Vet, HCW; Eertink, JJ; George Mikhaeel, N; Hoekstra, OS; Zijlstra, JM | 1 |
| Chen, Y; Hu, Z; Liu, H; Yang, X; You, Z | 1 |
| Bashir, H; Hassan, A; Siddiqui, N; Zafar, T | 1 |
| Barrington, SF; Boellaard, R; Burggraaff, CN; Carr, R; Ceriani, L; Czibor, S; de Vet, HCW; Dührsen, U; Eertink, JJ; Fanti, S; Györke, T; Heymans, MW; Hoekstra, OS; Hutchings, M; Hüttmann, A; Kostakoglu, L; Loft, A; Lugtenburg, PJ; Mikhaeel, NG; Müller, S; Pieplenbosch, S; Schmitz, C; Wiegers, SE; Zijlstra, JM; Zucca, E | 1 |
| Delmer, A; Durot, C; Durot, E; Gauchy, AC; Godard, F; Hoeffel, C; Morland, D; Papathanassiou, D; Zizi, G | 1 |
| Attygalle, A; Chau, I; Cunningham, D; El-Sharkawi, D; Goldman, A; Iyengar, S; Kowa, JY; Li, S; Mackinnon, A; Mahalingam, P; Marshall, K; Millard, T; Nicholson, E; Rich, P; Sharma, B; Sharma, RK; Welsh, L | 1 |
| Aide, N; Allioux, F; Gac, AC; Gandhi, D; Lasnon, C; Nganoa, C; Vilque, JP | 1 |
| Bagg, A; Ballard, HJ; Chong, EA; Farwell, MD; Hughes, ME; Namoglu, EC; Nasta, SD; Pantel, AR; Ruella, M; Ruff, A; Sellmyer, MA; Svoboda, J | 1 |
| Abrisqueta, P; Barba, P; Bobillo, S; Bosch, F; Carpio, C; Catalá, E; Díaz-Lagares, C; Iacoboni, G; Jiménez, M; Marín-Niebla, A; Pérez, A; Simó, M; Vidal-Jordana, Á; Villacampa, G | 1 |
| Berlangieri, S; Chong, G; Fancourt, T; Hannah, A; Hawkes, E; Lee, ST; Leung, T; Shen, E; Wai, SH; Wight, J | 1 |
| Bar-Shalom, R; Heching, N; Rosengarten, O; Ruchlemer, R; Turner, Y | 1 |
| Bansal, H; Chandrakar, PK; Krishna, S; Lukose, TT; Ravina, M | 1 |
| Lancellotti, P; Matsuyama, E; Mitamura, H; Nagatomo, Y; Tsugu, T | 1 |
| Chen, FL; Guo, HG; Huang, L; Huang, YY; Jiang, XM; Khong, PL; Li, WY; Liao, PJ; Liu, SC; Wang, SX; Wei, XJ; Yuan, H; Zhang, F | 1 |
| Boellaard, R; de Vet, HCW; Eertink, JJ; Hoekstra, OS; Lugtenburg, PJ; Pfaehler, EAG; van de Brug, T; van der Holt, B; Wiegers, SE; Zijlstra, JM; Zwezerijnen, GJC | 1 |
| Belada, D; Bolen, C; Chua, N; Ghiggi, C; González-Barca, E; Hong, X; Knapp, A; Kostakoglu, L; Martelli, M; Mattiello, F; Nielsen, T; Pinto, A; Sahin, D; Sehn, LH; Sellam, G; Shi, Y; Tatsumi, Y; Trněný, M; Vitolo, U | 1 |
| Alderuccio, JP; Barreto-Coelho, P; Beitinjaneh, A; Kuker, RA; Kwon, D; Lossos, IS; Martinez, BM; Miao, F; Moskowitz, CH; Reis, IM; Wang, TP | 1 |
| Cherng, HJ; Chuang, HH; Fayad, L; Feng, L; Flowers, CR; Hagemeister, F; Lee, HJ; Macapinlac, HA; Nair, R; Nastoupil, LJ; Neelapu, SS; Rodriguez, M; Samaniego, F; Steiner, R; Strati, P; Westin, J | 1 |
| Kang, S; Park, I | 1 |
| Kirito, K; Koshiishi, M; Kumagai, T; Mitsumori, T; Nakajima, K; Ooishi, S; Satoh, Y; Sueki, Y | 1 |
| Barton, H; Charles-Edwards, E; Chevassut, T; Dizdarevic, S; Teagle, AR | 1 |
| Casasnovas, RO; Le Gouill, S | 1 |
| Almonacid-Sánchez, C; Gorospe Sarasúa, L; Jaureguízar-Oriol, A; Rioja-Martín, ME | 1 |
| Cen, XN; Dong, YJ; Liang, ZY; Liu, W; Ou, JP; Qiu, ZX; Ren, HY; Sun, YH; Wang, LH; Wang, MJ; Wang, Q; Wang, WS; Xu, WL; Yin, Y; Zhu, LT | 1 |
| Avivi, I; Bar-Shalom, R; Benyamini, N; Dann, EJ; Farbstein, D; Lavi, N; Shapira, G; Zilberlicht, A | 1 |
| Botto, B; Cabras, MG; Ceriani, L; Conconi, A; Ferreri, AJM; Giovanella, L; Gotti, M; Johnson, PWM; Martelli, M; Rigacci, L; Stelitano, C; Zinzani, PL; Zucca, E | 1 |
| Bhartia, S; Sharma, P | 1 |
| Kim, J; Kim, SE; Lee, JS; Lee, WW; Song, YS | 1 |
| Aboulafia, DM; Lee, M; Mandelson, MT; Vishnu, P; Wingerson, A | 1 |
| Ali, SZ; Kin, KL; Poon, LM; Sinha, AK; Yin, LH | 1 |
| Colin, GC; Coulier, B; Floris, N; Scavée, C; Tourmous, H; Van Eeckhout, P | 1 |
| Delmer, A; Dupuis, J; Durot, E; Godet, S; Hivert, B; Ivanoff, S; Kanagaratnam, L; Le Dû, K; Leblond, V; Lemal, R; Leprêtre, S; Merabet, F; Michallet, AS; Morel, P; Perrot, A; Regny, C; Roussel, X; Sutton, L; Tomowiak, C; Toussaint, E; Van Den Neste, E; Zini, JM | 1 |
| Ai, L; Chen, Q; Dai, J; Fan, D; Jiang, T; Lin, S; Qiao, Z; Wang, K; Zhao, X | 1 |
| Lu, XL; Yu, L; Zhu, HY | 1 |
| Brand, C; Carney, B; Kossatz, S; Lewis, JS; Reiner, T; Sadique, A; Salloum, D; Tang, J; Weber, WA; Wendel, HG | 1 |
| Bolwell, BJ; Dean, R; Gerds, AT; Hamilton, BK; Hill, BT; Jagadeesh, D; Kalaycio, M; Liu, H; Majhail, NS; Pohlman, B; Rybicki, L; Shah, SN; Smith, M; Sobecks, R; Winter, A | 1 |
| Hertzberg, M | 1 |
| Abe, R; Jinzaki, M; Karigane, D; Kato, J; Kikuchi, T; Koda, Y; Mori, T; Nakahara, T; Nakazato, T; Okamoto, S; Sakurai, M; Shimizu, T; Toyama, T; Yamane, Y; Yamazaki, R | 1 |
| Baratto, L; Davidzon, GA; Hatami, N; Iagaru, A; Mittra, ES; Moghbel, M | 1 |
| Baldassarre, LA; Higgins, AY; Miller, EJ; Rosenfeld, LE; Taylor, EP | 1 |
| Chang, CC; Chang, SM; Cho, SF; Chuang, YW; Hsu, WL; Huang, YF; Lin, CY; Tu, HP | 1 |
| Chen, P; Jiang, M; Li, T; Ruan, X; Wang, Q; Wu, H; Wu, L; Xu, W; Zhou, W | 1 |
| Aide, N; Damaj, G; Fruchart, C; Lasnon, C; Talbot, M | 1 |
| Aide, N; Damaj, G; Enilorac, B; Fruchart, C; Gac, AC; Lasnon, C; Nganoa, C | 1 |
| Banjar, A; Becker, S; Desbordes, P; Gardin, I; Jardin, F; Ruminy, P; Tilly, H; Toledano, MN; Vera, P | 1 |
| Barnthouse, N; Chen, DL; Donald, JS | 1 |
| Henzlová, L; Papajík, T; Procházka, V; Ptáček, J | 1 |
| Ghez, D; Lazarovici, J; Terroir-Cassou-Mounat, M | 1 |
| Barrington, SF; Dunn, JT; Ilyas, H; Mikhaeel, NG; Møller, H; Rahman, F; Smith, D | 1 |
| Byun, JM; Choi, IS; Heo, DS; Keam, B; Kim, JS; Kim, KH; Kim, M; Kim, R; Kim, TM; Park, JH; Suh, KJ | 1 |
| Chang, CC; Cho, SF; Chuang, YW; Huang, YF; Lin, CY; Tyan, YC | 1 |
| Liu, G; Luo, R; Shi, H; Xiu, Y; Yin, H | 1 |
| Kuo, DJ; Paul, MR | 1 |
| Fan, Y; Li, Q; Liu, M; Wang, R; Zhang, J | 1 |
| Gou, Z; Zhao, Y; Zhou, J | 1 |
| Gómez León, N; Rodríguez-Vigil Junco, B; Suevos Ballesteros, C; Vega, G | 1 |
| Becker, S; Decazes, P; Desbordes, P; Gardin, I; Jardin, F; Tilly, H; Toledano, MN; Vera, P | 1 |
| Laffon, E; Marthan, R | 1 |
| Ceyrat, Q; Fernandez, P; Meyer, M; Tlili, G; Ziade, C | 1 |
| Ahn, JS; Ahn, SY; Bom, HS; Jung, SH; Ki, SY; Kim, HJ; Kwon, SY; Lee, JJ; Min, JJ; Song, SY; Yang, DH; Yoo, SW | 1 |
| Adams, HJA; Kwee, TC | 1 |
| Braziewicz, J; Hołody, Ł; Kunikowska, J | 1 |
| Baech, J; Cheah, CY; El-Galaly, TC; Gormsen, LC; Lo, A; Villa, D | 1 |
| Hino, A; Ishikawa, J; Kano, R; Masaie, H; Nagata, S; Nakatsuka, SI; Yasuoka, H | 1 |
| Kou, Y; Kuang, A; Liu, B; Shen, G | 1 |
| Ding, CY; Guo, Z; Li, TR; Sun, J; Yang, WP | 1 |
| Altinmakas, E; Medeiros, LJ; Ng, CS; Üçışık-Keser, FE | 1 |
| Abid, MB; Chan, EHL; de Mel, S; Loi, HY; Poon, LM; Wang, S | 1 |
| Burggraaff, CN; de Jong, A; de Vet, HCW; Heymans, MW; Hoekstra, OS; Hoetjes, NJ; Jansma, EP; Nievelstein, RAJ; Zijlstra, JM | 1 |
| Abe, K; Asano, T; Hishikawa, N; Inomata, T; Kawahara, Y; Ohta, Y; Sasaki, R; Sato, K; Tadokoro, K; Takahashi, Y; Takemoto, M; Yamashita, T | 1 |
| Kuang, A; Liu, B; Shen, G; Su, M | 1 |
| Chen, WY; Cui, YP; Gao, XR; Hu, JX; Hu, K; Li, ZZ; Zhang, YY | 1 |
| De Leiris, N; Djaileb, L; Leenhardt, J; Riou, L; Vuillez, JP | 1 |
| Kan, Y; Liu, J; Wang, W; Wang, Y; Yang, J | 1 |
| Barrington, SF; Dunn, JT; Ilyas, H; Mikhaeel, NG; Möller, H; Rahman, F; Smith, D | 1 |
| Hohaus, S; Lavalle, M; Manfredi, R; Minordi, LM; Rufini, V | 1 |
| Ganeshalingam, R; Roach, P; Schembri, GP | 1 |
| Cen, H; Guo, B; Ke, Q; Tan, X | 1 |
| Bari, A; Casolo, A; Cox, MC; D'Apollo, R; Franceschetto, A; Levy, I; Marcheselli, L; Marcheselli, R; Massi, L; Pizzichini, P; Pozzi, S; Prandini, N; Prosperi, D; Sacchi, S; Tadmor, T | 1 |
| Flowers, CR; Goldstein, J; Islam, P | 1 |
| Fu, LP; Guan, ZW; Li, F; Liu, CB; Wang, RM; Xu, BX; Zhu, HY | 1 |
| Bolzacchini, E; Campiotti, L; Casagrande, S; DE Palma, D; Guasti, L; Ogliari, F; Proserpio, I; Schiorlin, I; Squizzato, A; Suter, M | 1 |
| Lim, K; Maingard, J; Nambiar, M; Tai, R | 1 |
| Chague, P; Cottereau, AS; Lapusan, S; Phan, CM; Zhang-Yin, J | 1 |
| Hashimoto, A; Ishihara, M; Miyoshi, H; Ohshima, K; Shinzato, I; Tanaka, Y | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, EE; Koh, Y; Lee, DS; Shagera, QA; Yoo, MY; Yoon, SS | 1 |
| Barrington, SF; Meignan, M | 1 |
| Keane, C; Yoon Cheah, C | 1 |
| Boellaard, R; Diepstra, A; Hovingh, M; Huls, G; Kahle, XU; Kwee, TC; Nijland, M; Noordzij, W; Seitz, A; van den Berg, A; van Meerten, T; Visser, L | 1 |
| Dierickx, D; Gheysens, O; Goffin, K; Laenen, A; Tousseyn, T; Van Keerberghen, CA; Vandenberghe, P; Vergote, V; Verhoef, G | 1 |
| Adachi, M; Ito, Y; Nagata, Y; Nakano, K; Ono, T; Sakamoto, N; Takaba, M; Takagi, F; Takemura, T; Uchiyama, S; Yoda, A | 1 |
| Kostakoglu, L; Nowakowski, GS | 1 |
| Haikerwal, D; Thayaparan, AS | 1 |
| Rutherford, SC | 1 |
| Chmielowska, E; Kuliczkowski, K; Małkowski, B; Olejniczak, M; Rybka, J; Sokołowska, E; Wróbel, T | 1 |
| Lan, X; Li, J; Li, X; Liu, Z; Mi, M; Sun, X; Wu, G; Zhang, L; Zhu, F | 1 |
| Hu, K; Song, L; Zhang, YY; Zhao, MX | 1 |
| Araz, M; Demirer, T; Ozkan, E; Ozturk, C; Soydal, C | 1 |
| Bordenave, L; Bouabdallah, K; Hindié, E; Mesguich, C; Milpied, N; Roch, A; Tlili, G | 1 |
| Avivi, I; Bar-Shalom, R; Dann, EJ; Faibish, T; Leiba, R; Rowe, JM; Zilberlicht, A | 1 |
| Qiao, W; Wang, C; Wang, T; Xing, Y; Zhao, J | 1 |
| Antic, D; Mihaljevic, B; Pelemis, M; Perunicic, M; Petrovic, N; Stevanovic, G | 1 |
| Climent-Esteller, F; Cortés-Romera, M; Gámez-Cenzano, C; González-Barca, E; Mercadal-Vilchez, S; Sabaté-Llobera, A; Serrano-Maestro, A | 1 |
| Berriolo-Riedinger, A; Biggi, A; Casasnovas, RO; Cashen, AF; Gallamini, A; Haioun, C; Itti, E; Meignan, M; Siegel, BA; Tilly, H; Véra, P | 1 |
| Hatanaka, KC; Ito, YM; Kikuchi, Y; Manabe, O; Naya, M; Oyama-Manabe, N; Shirato, H; Tamaki, N; Terae, S; Tsutsui, H | 1 |
| Buriánková, E; Flodr, P; Formánek, R; Henzlová, L; Indrák, K; Jarošová, M; Kapitáňová, Z; Mysliveček, M; Papajík, T; Procházka, V; Turcsányi, P; Urbanová, R | 1 |
| Berriolo-Riedinger, A; Berthet, L; Brunotte, F; Casasnovas, O; Cochet, A; Dygai-Cochet, I; Humbert, O; Kanoun, S; Legouge, C; Toubeau, M | 1 |
| Hattori, S; Hayabuchi, N; Hayakawa, M; Hirose, Y; Ishibashi, M; Kage, M; Kaida, H; Kawahara, A; Kunou, Y; Kurata, S; Ohshima, K; Okamura, T; Suefuji, H; Watanabe, Y | 1 |
| Ellmann, A | 1 |
| Bargay, J; Bello, JL; Caballero, D; Canales, M; Cortés, M; Donato, E; Ferrer, S; González-Barca, E; Oriol, A; Salar, A; Sánchez, JJ; Tomás, JF; Vidal, MJ | 1 |
| André, M; Bosly, A; Bouazza, S; Costantini, S; Lhommel, R; Michaux, L; Mounier, N; Nols, N; Sonet, A; Van Den Neste, E; Vander Borght, T; Vekemans, MC | 1 |
| Adams, HJ; Kwee, TC; Nievelstein, RA | 3 |
| Choi, JY; Hong, JY; Jung, CW; Kim, HJ; Kim, SJ; Kim, WS; Ko, YH | 1 |
| Creager, MA; LaCasce, AS; Leibner, HA; Ramaiya, NH; Tirumani, SH; Weinblatt, ME | 1 |
| Berthet, L; Cochet, A; Humbert, O | 1 |
| Fang, Y; Huang, WT; Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, H; Zhang, WJ; Zheng, R | 1 |
| Brown, P; Christiansen, I; El-Galaly, TC; Gerke, O; Gillstrøm, D; Himmelstrup, B; Hutchings, M; Jensen, P; Munksgaard, L; Mylam, KJ; Nielsen, AL; Pedersen, BB; Pedersen, LM; Sillesen, IB | 1 |
| Han, JK; Pan, B; Wang, SC; Xu, A | 1 |
| Ceriani, L; Giovanella, L; Paone, G; Perriard, U; Treglia, G | 1 |
| Bahlis, NJ; Bence-Bruckler, I; Duggan, P; Kloiber, R; Mansoor, A; Owen, C; Stewart, DA | 1 |
| Bal, C; Dhull, VS; Jain, S; Kumar, R; Sharma, P | 1 |
| Gönen, M; Lilienstein, J; Maragulia, J; Moskowitz, CH; Ulaner, GA; Zelenetz, AD | 1 |
| Adams, HJ; de Keizer, B; de Klerk, JM; Fijnheer, R; Kwee, TC; Nievelstein, RA | 1 |
| Huang, G; Lu, J; Song, S; Wei, X; Zhu, Y | 1 |
| Fukayama, M; Hosoi, A; Kurokawa, M; Nakamura, F; Nakazaki, K; Nannya, Y; Shinozaki-Ushiku, A; Uni, M; Yoshimi, A | 1 |
| Capacchione, D; Gallicchio, R; Gattozzi, D; Guariglia, R; Mansueto, G; Musto, P; Nardelli, A; Pedicini, P; Simeon, V; Soscia, E; Storto, G | 1 |
| Hagihara, M; Hattori, Y; Ishigatsubo, Y; Ishii, Y; Ishiyama, Y; Tateishi, U; Tomita, N; Yamamoto, E; Yamazaki, E | 1 |
| Casasnovas, RO; Coriani, C; Fioroni, F; Gobbi, PG; Itti, E; Luminari, S; Masset, H; Meignan, M; Merli, F; Sasanelli, M; Versari, A | 1 |
| Gallamini, A; Polliack, A | 1 |
| Apter, S; Avigdor, A; Ben-Bassat, I; Berkowicz, M; Davidovitz, Y; Davidson, T; Goshen, E; Kedmi, M; Kneller, A; Merkel, D; Nagler, A; Ribakovsy, E; Shimoni, A; Sirotkin, T; Volchek, Y | 1 |
| Buck, AK; Herrmann, K; Knott, M; Lapa, C; Rasche, L; Rosenwald, A | 1 |
| Borra, A; Gallamini, A | 1 |
| Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Kwee, TC; Nievelstein, RA | 5 |
| Arzu, I; Dabaja, BS; Fayad, LE; Hagemeister, FB; Hess, K; Kedir, A; Mawlawi, O; Medeiros, LJ; Oki, Y; Podoloff, DA; Reed, VK; Rodriguez, A; Shihadeh, F; Wogan, CF | 1 |
| Ding, C; Ding, Q; Fan, L; Li, J; Li, T; Sun, J; Xu, W | 1 |
| Balzarotti, M; Brusamolino, E; Cabras, MG; Cavalli, F; Ceriani, L; Davies, A; Ferreri, AJ; Finolezzi, E; Giovanella, L; Johnson, PW; Lopez-Guillermo, A; Martelli, M; Montoto, S; Pileri, SA; Rigacci, L; Salvi, F; Stelitano, C; Vitolo, U; Zinzani, PL; Zucca, E | 1 |
| Hamlin, PA | 1 |
| Chetaille, B; Colavolpe, C; Coso, D; Ebbo, M; Franques, J; Gastaud, L; Guedj, E; Khibri, H; Ouvrier, MJ; Schleinitz, N; Trousse, D | 1 |
| Basturk, A; Kilicarslan, A; Ozdemir, E; Turkolmez, S; Yildirim-Poyraz, N | 1 |
| Berriolo-Riedinger, A; Biggi, A; Casasnovas, RO; Cashen, AF; Gallamini, A; Haioun, C; Itti, E; Meignan, M; Sasanelli, M; Siegel, BA; Tilly, H; Véra, P; Versari, A | 1 |
| Dastidar, P; Eskola, H; Järvenpää, R; Kellokumpu-Lehtinen, PL; Korkola, P; Pertovaara, H; Vornanen, M; Wu, X | 1 |
| Cai, L; Fu, D; Fu, W; Gui, S; Li, J; Li, W; Lu, B; Tang, R; Yang, P; Zhang, H | 1 |
| Arranz, R; Bargay, J; Bello, JL; Caballero, MD; Conde, E; Coronado, M; González-Barca, E; Grande, C; Hernández, MT; Marín-Niebla, A; Martín, A; Montes-Moreno, S; Panizo, C; Pardal, E; Pérez-Ceballos, E | 1 |
| Akagi, A; Hamaguchi, T; Nakada, M; Ono, K; Oohata, T; Samuraki, M; Shima, Y; Yamada, M | 1 |
| Fujimi, A; Furuichi, K; Hara, A; Hashimoto, A; Hayasaka, N; Iwata, Y; Iyama, S; Kamihara, Y; Kanisawa, Y; Kato, J; Minami, S; Nakajima, C; Okuda, T; Sato, T; Takada, K; Uemura, N; Wada, T | 1 |
| Bradley, KM; Green, AL; Teoh, EJ | 1 |
| Patel, CN; Robinson, RJ; Tachibana, A | 1 |
| Akai, T; Iizuka, H; Sasagawa, Y; Tachibana, O | 1 |
| Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Heggelman, BG; Kwee, TC; Nievelstein, RA | 3 |
| Iwama, H; Kojima, M; Tabata, C; Tabata, R; Yasumizu, R | 1 |
| Brown, Pde N; Coleman, M; Czuczman, MS; Diehl, LF; Eriksson, M; Gillstrøm, D; Hansen, PB; Hendel, HW; Hjorthaug, K; Holte, H; Hutchings, M; Iyer, V; Jensen, P; Jyrkkiö, S; Kostakoglu, L; Lamonica, D; Leppä, S; Loft, A; Mylam, KJ; Nielsen, AL; Pedersen, LM; Seppänen, M | 1 |
| Ando, K; Kim, WS; Niitsu, N; Ogura, M; Suh, C; Tateishi, U; Tatsumi, M; Terauchi, T; Tobinai, K | 1 |
| Jiang, Q; Liu, Y; Wu, K; Xie, M; Xie, Y | 1 |
| Bhattacharya, A; Biswal, CK; Mittal, BR; Prabhakar, S; Shukla, J; Vatsa, R | 1 |
| Bai, X; Codreanu, I; Kaplan, SL; Servaes, S; Zhuang, H | 1 |
| Coughlan, M; Elstrom, R | 1 |
| Castillo, JJ; Reagan, JL; Sikov, WM; Winer, ES | 1 |
| Ding, C; Ding, Q; Li, T; Sun, J; Xu, X; Yang, W | 1 |
| Doshi, JA; Huntington, SF; Nasta, SD; Schuster, SJ; Svoboda, J | 1 |
| Koury, M; Richardson, T; Shah, C; Thota, R | 1 |
| Yang, Y; Yu, L; Zhu, HY | 1 |
| Chung, JS; Kim, SJ; Kim, SS; Shin, HJ; Song, MK | 1 |
| Dong, Y; Li, H; Tian, Y; Wang, Q; Wu, H; Zhou, W | 1 |
| Barker, DW; Gru, AA; Natwa, M; Samarghandi, A | 1 |
| Chen, Y; Huang, Z; Qiu, L; Wen, Q; Zhu, Y | 1 |
| Devlin, SM; Hilden, P; Matasar, MJ; Meikle, J; Migliacci, JC; Moskowitz, CH; Sauter, CS; Schoder, H; Ulaner, GA; Zelenetz, AD | 1 |
| Chen, PM; Chiou, TJ; Gau, JP; Hsiao, LT; Liu, CY; Liu, JH; Tzeng, CH; Yang, CF; Yang, SH; Yu, YB | 1 |
| Moskowitz, CH; Schöder, H | 1 |
| Doshi, JA; Huntington, SF; Svoboda, J | 1 |
| Advani, RH; Gascoyne, R; Habermann, TM; Hong, F; Horning, SJ; Kahl, BS; Li, H; Quon, A; Ranheim, EA; Swinnen, LJ | 1 |
| Ahmed, MA; Ahmed, S; Chuang, HH; Costelloe, C; Dabaja, B; Davis, RE; Fanale, MA; Fayad, L; Fowler, N; Hagemeister, FB; Khouri, IF; Medeiros, LJ; Nastoupil, L; Neelapu, S; Nieto, Y; Oki, Y; Pinnix, CC; Reed, V; Rodriguez, MA; Romaguera, JE; Turturro, F; Westin, J; Wogan, CF | 1 |
| Borrego-Dorado, I; García-Gómez, FJ; Madrigal-Toscano, MD; Martínez-Esteve, A | 1 |
| Iliin, NV; Vinogradova, YN | 1 |
| Hutchings, M; Mylam, KJ; Nielsen, AL; Pedersen, LM | 1 |
| Adams, HJ; Kwee, TC | 5 |
| Botto, B; Cabras, MG; Cavalli, F; Ceriani, L; Ferreri, AJ; Gargantini, L; Giovanella, L; Gotti, M; Johnson, PW; Luminari, S; Mannina, D; Martelli, M; Merli, F; Pinotti, G; Rigacci, L; Russo, E; Stathis, A; Stelitano, C; Zinzani, PL; Zucca, E | 1 |
| Bai, J; Cai, H; Cao, X; Chen, M; Duan, M; Li, J; Zhang, W; Zhang, Y; Zhou, D; Zhu, Z; Zhuang, J | 1 |
| Cassou-Mounat, T; Cayssials, E; Delwail, V; Puyade, M; Terroir, M | 1 |
| Bargetzi, M; Biaggi, C; Dirnhofer, S; Driessen, C; Gigli, F; Hany, T; Hitz, F; Klingbiel, D; Krasniqi, F; Mamot, C; Martinelli, G; Mey, U; Pabst, T; Pless, M; Renner, C; Rusterholz, C; Samarin, A; Zucca, E | 1 |
| Advani, RH; Binkley, MS; Hiniker, SM; Hoppe, RT; Mittra, ES; Natkunam, Y; Wu, S | 1 |
| Bøgsted, M; de Nully Brown, P; El-Galaly, TC; Gang, AO; Gormsen, LC; Hendel, HW; Hutchings, M; Iyer, V; Loft, A; Madsen, J; Mylam, KJ; Nielsen, AL; Pedersen, MB | 1 |
| Alzahrani, M; Connors, JM; de Nully Brown, P; El-Galaly, TC; Hansen, JW; Hutchings, M; Iyer, V; Johnsen, HE; Loft, A; Savage, KJ; Sehn, LH; Villa, D; Wilson, D | 1 |
| Ding, CY; Fang, L; Li, TN; Liu, HY; Xu, W | 1 |
| Berenji, G; Lewis, M; Ni, C | 1 |
| Fan, Y; Song, Y; Wang, X; Yang, Z; Ying, Z; Zhang, Y; Zhu, J | 1 |
| Adams, HJA; de Klerk, JMH; Dubois, SV; Fijnheer, R; Heggelman, BGF; Kwee, TC; Nievelstein, RAJ | 1 |
| Zhang, W; Zhao, M | 1 |
| Kim, SE; Lee, JS; Lee, WW; Song, YS | 1 |
| Ahlman, MA; Grayson, PC; Hughes, M; Malayeri, AA; Newman, KA; Pratt, D | 1 |
| Hsiao, PC; Kao, PF; Kao, YL; Weng, JH | 1 |
| An, YS; Jeong, SH; Kang, DR; Kim, J; Kwon, SH; Lee, HW; Lee, SJ; Yoon, JK | 1 |
| Mamot, C | 1 |
| Dubreuil, J; Giammarile, F; Moreau, A; Salles, G; Sarkozy, C; Skanjeti, A; Traverse-Glehen, A | 1 |
| Advani, R; Fayad, L; Hankins, J; Juweid, M; Macapinlac, H; Meza, J; Minamimoto, R; Mottaghy, F; Quon, A; Vose, J | 1 |
| Han, J; Kong, Y; Li, Y; Liu, D; Lv, X; Qu, L | 1 |
| de Jong, A; de Keizer, B; Hoekstra, OS; Mous, R; Nievelstein, RA; van Dongen, GA | 1 |
| Shi, B; Wang, Z; Wu, F; Xing, X; Yu, M | 1 |
| Becker, S; Cottereau, AS; Jardin, F; Lanic, H; Mareschal, S; Meignan, M; Tilly, H; Vera, P | 2 |
| Akasaka, T; Fukutsuka, K; Honjo, G; Iioka, F; Izumi, K; Kamoda, Y; Kitamura, K; Misaki, T; Nagai, Y; Nakagwa, M; Ohno, H; Okumura, A; Toda, Y | 1 |
| Alzahrani, M; Brown, P; Clasen-Linde, E; Connors, JM; El-Galaly, TC; Gascoyne, RD; Hansen, JW; Hutchings, M; Iyer, V; Johansen, P; Johnsen, HE; Loft, A; Savage, KJ; Sehn, LH; Villa, D; Wilson, D | 1 |
| Bishton, MJ; Fox, CP; McMillan, AK | 1 |
| Kok, TY; Neo, SH; Tong, AK | 1 |
| Esbah, AÜ; Esbah, O; Öneç, B; Öneç, K | 1 |
| Barrington, SF; Mikhaeel, NG | 1 |
| Aktürk, S; Altınbaş, NK; Erdoğmuş, Ş; Kaygusuz, G; Kendi Çelebi, Z; Keven, K; Kiremitçi, S; Üstüner, E | 1 |
| Cheson, BD; Cordova, C; Esposito, G; Hill, EM; Nassif, S; Ozdemirli, M; Ujjani, CS; Wang, H | 1 |
| Awan, UK; Bashir, H; Basit, A; Hameed, A; Khan, SA; Muzaffar, N; Siddiqui, N | 1 |
| Abdel Rahman, H; Hamoda, A; Hassanein, O; Moussa, E; Omar, W; Raafat, T; Sedky, M; Youssef, A | 1 |
| Nie, P; Wang, Z; Xing, X; Yang, G | 1 |
| Liu, YM; Wu, YW; Zhai, XM | 1 |
| An, YS; Jeong, SH; Lee, HW; Lee, SJ; Yoon, JK | 1 |
| Chen, F; Chen, Y; Fang, Y; Han, X; Huang, H; Liu, J; Liu, Q; Ni, B; Shen, L; Shi, Y; Wang, J; Wang, T; Xiao, F; Xu, L; Zhang, M; Zheng, L; Zhong, H; Zhong, L; Zhu, J | 1 |
| Cavalli, F; Ceriani, L; Zucca, E | 1 |
| Demeter, J; Paksi, M; Szabó, P | 1 |
| Coutinho, AM; de Oliveira Costa, R; de Paula, HM; Hallack Neto, A; Lage, LA; Pereira, J; Siqueira, S | 1 |
| Hsieh, TC; Kao, CH; Liao, CW; Yen, KY | 1 |
| Gergely, L; Illés, Á | 1 |
| Afaq, A; Akin, O; Ardeshna, K; Chen, SH; Fraioli, F; Groves, A; Kayani, I; Lambert, J; Linch, D; Miles, K; Punwani, S; Sidhu, H; Wan, S | 1 |
| Cho, SG; Choi, BO; Han, EJ; Jung, SE; O, JH; Park, G; Yoon, H | 1 |
| Barrington, SF; Burggraaff, CN; Kersten, MJ; Zijlstra, JM | 1 |
| Balev, B; Bochev, P; Bocheva, Y; Chaushev, B; Dancheva, J; Ivanova, D; Klisarova, A; Krasnaliev, I; Lozanova, R; Mechmed, M; Micheva, I | 1 |
| Chen, Y; Huang, G; Huang, H; Liu, J; Zhou, M; Zhou, X | 1 |
| Cheson, BD; Kostakoglu, L | 1 |
| Bou-Orm, IR; El Cheikh, J; El Karak, F; Farhat, F; Ghosn, M; Haidar, M; Ibrahim, T; Jreige, M; Kattan, J | 1 |
| Butcher, B; Chong, G; Cull, G; Fay, K; Filshie, R; Gandhi, MK; Gill, D; Grigg, A; Hahn, U; Hertzberg, M; Hicks, RJ; Ho, SJ; Hofman, MS; Johnston, A; Kannourakis, G; Lewis, ID; Milliken, S; Renwick, W; Seymour, JF; Taper, J; Trotman, J; Warburton, P; Watson, AM; Wirth, A | 1 |
| Bhattarai, A; Eskola, H; Kellokumpu-Lehtinen, PL; Korkola, P; Pertovaara, H; Wu, X | 1 |
| Higashiyama, A; Inada, Y; Komori, T; Nakajima, H; Narumi, Y | 1 |
| Inubushi, M; Nagai, K; Sone, T; Takeuchi, S | 1 |
| Higashi, K; Ishida, C; Kotani, T; Okino, S; Shima, K; Yamada, M | 1 |
| Alousi, AM; Anderlini, P; Champlin, RE; de Lima, M; Giralt, SA; Hosing, C; Kebriaei, P; Khouri, IF; Korbling, M; Macapinlac, HA; Okoroji, GJ; Popat, U; Qazilbash, MH; Saliba, RM; Samuels, BI | 1 |
| Alinari, L; Baccarani, M; Derenzini, E; Fanti, S; Gandolfi, L; Musuraca, G; Stefoni, V; Tani, M; Venturini, F; Zinzani, PL | 1 |
| Il'in, NV; Ivanova, AA; Ivanova, EI; Ryzhkova, DV; Savchenko, ON; Tiutin, LA; Tlostanova, MS; Vinogradova, IuN | 1 |
| Belhadj, K; Copie-Bergman, C; Dupuis, J; El Gnaoui, T; Gaillard, I; Gisselbrecht, C; Haioun, C; Hemery, F; Itti, E; Kuhnowski, F; Lin, C; Meignan, M; Rahmouni, A | 1 |
| Dupuis, J; Gaulard, P; Haioun, C; Itti, E; Lin, C; Meignan, M; Paone, G | 1 |
| Hamlin, PA; Hoppe, BS; Maragulia, JC; Moskowitz, CH; Reiner, AS; Rice, RD; Yahalom, J; Zelenetz, AD; Zhang, Z | 1 |
| Fan, W; Lin, XP; Zhang, X | 1 |
| Chen, HD; He, CD; Liu, M; Shan, SJ; Wei, HC; Wu, J; Xiao, T; Yin, YF | 1 |
| Kim, H; Kim, SE; Lee, WW; Park, SY; Shim, HK; So, Y | 1 |
| Bardet, S; Couturier, O; Hotta, T; Hutchings, M; Lau, J; Nagai, H; Nihashi, T; Terasawa, T | 1 |
| Capacchione, D; Dupuis, J; Haioun, C; Itti, E; Lin, C; Meignan, M; Paone, G; Rahmouni, A | 1 |
| Chen, ML; Hou, SM; Huang, HL; Su, HY; Sun, CM | 1 |
| Chen, SH; Chuang, WY; Lin, TL; Yen, TC; Yu, KH | 1 |
| Asaka, M; Kasai, M; Kawamura, N; Kiyama, Y; Kudo, M; Nakata, M; Natsuizaka, M; Noguchi, S; Ogasawara, M; Suzuki, M; Takano, M; Tsuyuguchi, M; Wada, A | 1 |
| Aono, M; Matsuo, K; Shimada, H; Yago, K; Yanagita, S | 1 |
| Choi, JY; Kim, BT; Kim, SJ; Kim, WS; Ko, YH; Yi, JH | 1 |
| Fan, W; Ma, LF | 1 |
| Basu, S; Lad, S; Ramani, SK | 1 |
| Akpinar, T; Aydin, O; Baran, I; Bicer, M; Gullulu, S; Kaderli, AA; Ozkalemkas, F; Yesilbursa, D | 1 |
| Advani, R; Gascoyne, R; Horning, SJ; Juweid, ME; McMillan, A; Quon, A; Schöder, H; Swinnen, LJ; Wiseman, G | 1 |
| Gallamini, A; Haioun, C; Itti, E; Meignan, M | 1 |
| Nagai, H; Terasawa, T | 1 |
| Ichikawa, T; Ichimura, K; Kaji, M; Matsuo, T; Okumura, Y; Yoshino, T | 1 |
| Mikhaeel, NG | 1 |
| Gomes, H; Kalkani, M; Kalkanis, D; Paes, F; Sfakianakis, GN; Sideras, P | 1 |
| Carrasquillo, JA; Dunleavy, K; Grant, N; Jaffe, ES; Little, RF; Pittaluga, S; Steinberg, SM; Wayne, AS; Wilson, WH; Yarchoan, R | 1 |
| Haile, SR; Hany, TF; Knuth, A; Mischo, A; Petrausch, U; Renner, C; Samaras, P; Schäefer, NG; Soyka, JD; Veit-Haibach, P | 1 |
| Allmer, C; Gingrich, RD; Habermann, TM; Jacobus, L; Link, BK; Maurer, MJ; Ristow, K; Smith, BJ; Thomas, A | 1 |
| Chihara, D; Ine, S; Kagami, Y; Kato, H; Morishima, Y; Oki, Y; Onoda, H; Taji, H; Yamamoto, K | 1 |
| Fan, W; Li, W | 1 |
| Moskowitz, CH; Schoder, H; Zelenetz, A | 1 |
| Caravelli, JF; Filippa, DA; Hamlin, PA; Horwitz, S; Iasonos, A; Meikle, JL; Moskowitz, CH; Noy, A; O'Connor, OA; Palomba, ML; Portlock, CS; Schöder, H; Sima, C; Straus, D; Teruya-Feldstein, J; Weaver, SA; Zelenetz, AD | 1 |
| Haerle, SK; Hälg, RA; Huber, GF; Schaefer, N; Schrepfer, T; Strobel, K | 1 |
| Dickinson, M; Grigg, A; Hoyt, R; Prince, HM; Ritchie, D; Roberts, AW; Seymour, JF; Szer, J | 1 |
| Huang, YT; Lee, JC; Platts, DG; Slaughter, RE | 1 |
| Boslooper, K; Dal, M; Dijkhuizen, D; Hoogenberg, K; Meilof, JF; van der Velden, AW | 1 |
| Bodet-Milin, C; Dubruille, V; Gastinne, T; Harousseau, JL; Jardel, H; Juge-Morineau, N; Kraeber-Bodéré, F; Le Gouill, S; Mahé, B; Maisonneuve, H; Mohty, M; Moreau, A; Moreau, P; Planche, L; Roland, V | 1 |
| Dührsen, U; Hüttmann, A; Jöckel, KH; Müller, S | 1 |
| Miura, Y; Tsudo, M | 1 |
| Beaven, AW; Chino, JP; Coleman, RE; Diehl, LF; Dorth, JA; Kelsey, CR; Prosnitz, LR | 1 |
| Itti, E; Juweid, ME; Meignan, M; Smith, B | 1 |
| Amadori, D; Asioli, S; Cangini, D; Ceccolini, M; Fattori, PP; Giannini, MB; Matteucci, F; Musuraca, G; Ronconi, S | 1 |
| Dupuis, J; El Bez, I; Evangelista, E; Haioun, C; Hamza-Maaloul, F; Itti, E; Juweid, ME; Lin, C; Meignan, M; Yeddes, I | 1 |
| Fang, J; Luo, XM; Ruan, LX; Yan, SX; Yao, HT; Zhou, SH | 1 |
| Gaillard, I; Haioun, C; Itti, E; Kuhnowski, F; Lin, C; Lin, SJ; Luciani, A; Meignan, M; Paone, G; Pigneur, F; Rahmouni, A; Zegai, B | 1 |
| Hosokai, R; Imai, C; Imamura, M; Iwabuchi, H; Takachi, T; Uchiyama, M; Yoshida, S | 1 |
| Ahn, JS; Bae, SY; Bom, HS; Chung, IJ; Chung, WK; Jeong, YY; Kim, HJ; Kim, YK; Lee, JJ; Min, JJ; Song, HC; Yang, DH | 1 |
| Dastidar, P; Eskola, H; Kellokumpu-Lehtinen, PL; Korkola, P; Pertovaara, H; Soimakallio, S; Wu, X | 1 |
| Ramsdale, E; Smith, SM; van Besien, K | 1 |
| Bardet, S; Berriolo-Riedinger, A; Bologna, S; Brière, J; Casasnovas, RO; Coiffier, B; Haioun, C; Jais, JP; Julian, A; Meignan, M; Morschhauser, F; Thieblemont, C; Vera, P | 1 |
| Arima, N; Fukuda, K; Kishi, H; Tsuda, H | 1 |
| Eskola, H; Järvenpää, R; Kellokumpu-Lehtinen, PL; Korkola, P; Pertovaara, H; Wu, X | 1 |
| Bagdi, E; Demeter, J; Krenács, L; Répássy, G; Sári, E; Szabó, P; Tamás, L | 1 |
| Ambrogi, V; Cavalieri, E; Cox, MC; Lanni, V; Marchetti, P; Monarca, B; Pelliccia, S; Scopinaro, F; Spiriti, MA | 1 |
| Celen, Z; Erkilic, S; Kalender, E; Yilmaz, M | 1 |
| Ciarallo, A; Lisbona, R; Makis, W | 1 |
| Eskola, H; Kellokumpu-Lehtinen, PL; Korkola, P; Pertovaara, H; Vornanen, M; Wu, X | 1 |
| Akamatsu, T; Arakura, N; Haba, S; Ishida, F; Ito, T; Iwaya, Y; Kaneko, Y; Matsuda, K; Muraki, T; Nakazawa, H; Sano, K; Takenaka, K; Tanaka, E; Yamada, Y | 1 |
| Ahn, JY; Hong, J; Hwang, KH; Jeong, J; Kim, KH; Kim, SG; Lee, JH; Lee, Y; Park, J; Park, S; Park, SH; Park, Y | 1 |
| Chung, DS; Chung, JS; Kim, SJ; Lee, GW; Lee, HS; Lee, SE; Lee, SM; Shin, HJ; Song, MK | 1 |
| Kundu, M; Metzger, ML; Otto, M; Sandlund, JT; Shulkin, BL; Snyder, SE | 1 |
| Chan, KW; Chan, T; Cheung, C; Hung, KN; Kwong, YL; Lopes, D | 1 |
| Bardet, S; Copie-Bergman, C; Dupuis, J; Fruchart, C; Haioun, C; Itti, E; Jardin, F; Meignan, M; Rahmouni, A; Safar, V; Tilly, H; Véra, P | 1 |
| Fujitani, Y; Inaba, A; Kosaka, S; Ohta, K; Okamura, T; Senzaki, H; Takeoka, Y; Yamamura, R | 1 |
| Bellò, M; Bisi, G; Botto, B; Chiappella, A; Ferrero, S; Franceschetti, S; Giunta, F; Ladetto, M; Limerutti, G; Menga, M; Nicolosi, M; Passera, R; Pregno, P; Priolo, G; Puccini, B; Rigacci, L; Salvi, F; Vaggelli, L; Vitolo, U | 1 |
| Beyne-Rauzy, O; Brechemier, D; Dugert, E; Hitzel, A; Julian, A; Le Guellec, S; Wagner, T | 1 |
| Il'in, NV; Khodzsibekova, MM; Kostenikov, NA; Mukhina, MS; Pozharisskiĭ, KM; Tiutin, LA | 1 |
| Mikhaeel, NG; Yeoh, KW | 1 |
| Catalano, PJ; Halasz, LM; Jacene, HA; Lacasce, A; Mauch, PM; Ng, AK; Van den Abbeele, AD | 1 |
| Dewar, R; Freedman, AS; Giardino, AA; Mauch, P; Ramaiya, NH; Shinagare, AB; Shinagare, SA; Weckstein, D | 1 |
| Asselain, B; Bénamor, M; Decaudin, D; Dendale, R; Moulin-Romsee, G; Plancher, C; Rouic, LL; Sahli, R; Servois, V; Validire, P; Vincent-Salomon, A; Zanni, M | 1 |
| Berriolo-Riedinger, A; Casasnovas, RO; Haioun, C; Huglo, D; Itti, E; Meignan, M; Morschhauser, F | 1 |
| Ahn, HK; Cho, SH; Choi, JY; Hwang, DW; Ji, JH; Kim, SJ; Kim, WS; Lee, JY; Maeng, CH; Moon, SH; Park, LC; Park, S | 1 |
| Cheon, GJ; Choe, JG; Jeong, E; Lee, S; Oh, SY; Pahk, K; Park, TG | 1 |
| Danga, A; Hemmaway, CJ; Igbokwe, U; Radunovic, A | 1 |
| Stübgen, JP | 1 |
| Cheng, G | 1 |
| Ando, Y; Fujii, M; Kato, K; Maesawa, S; Naganawa, S; Nihashi, T; Okada, Y; Okochi, Y; Takebayashi, S; Wakabayashi, T; Yamashita, M | 1 |
| Anthony, MP; Khong, PL; Lee, EY; Tsang, HH | 1 |
| Carli, P; Cournac, JM; de Jaureguiberry, JP; Fauchais, AL; Landais, C; Paris, JF; Poisnel, E | 1 |
| Fujita, H; Minatani, Y; Miyagaki, T; Ohmatsu, H; Ohno, Y; Sato, S; Sugaya, M; Sumida, H; Uwajima, Y; Yamashita, H | 1 |
| Ceriani, L; Giovanella, L; Ruberto, T; Suriano, S; Zucca, E | 1 |
| Abdelsalam, M; Abouzied, M; Akhtar, S; Al-Sugair, AS; Alkadhi, Y; Darwish, A; Dingle, M; Elhassan, TA; Eltigani, A; Maghfoor, I; Nabil-Ahmed, M; Soudy, H | 1 |
| García Vicente, AM; Hernández Ruiz, B; Jiménez Londoño, GA; Soriano Castrejón, Á | 1 |
| Aichler, M; Buck, AK; Dechow, T; Feuchtinger, A; Graf, N; Herrmann, K; Keller, U; Numberger, B; Peschel, C; Schuster, T; Schwaiger, M; Senekowitsch-Schmidtke, R; Wester, HJ; Zwisler, D | 1 |
| Hara, M; Kohashi, S; Miyagawa, M; Miyazaki, Y; Nakase, K; Nawa, Y; Yasukawa, M | 1 |
| Hong, J; Lee, JH | 1 |
| Aliyev, A; Asa, S; Erkan, ME; Halac, M; Sager, S; Yılmaz, S | 1 |
| Hsieh, TC; Kao, CH; Shen, YY; Yen, KY | 1 |
| Chun, IK; Chung, JK; Heo, DS; Jeon, YK; Keam, B; Kim, CW; Kim, DW; Kim, IH; Kim, TM; Lee, DS; Lee, SH; Paeng, JC | 1 |
| Ahn, JS; Bom, HS; Byun, BH; Chae, YS; Jung, SH; Kim, HJ; Kim, HW; Kim, YK; Kweon, SS; Lee, JJ; Lee, SW; Min, JJ; Sohn, SK; Yang, DH | 1 |
| Kalra, M; Scott, J; Wang, Y | 1 |
| Akashi, K; Daisaki, H; Harada, M; Kato, K; Nishida, H; Numata, A; Shimada, N; Suzuki, K; Tateishi, U; Tatsumi, M; Terauchi, T | 1 |
| Bailly, C; Bodet-Milin, C; Dupas, B; Eugène, T; Gastinne, T; Kraeber-Bodéré, F; Le Gouill, S | 1 |
| Han, JK; Ni, M; Pan, B; Wang, CS; Xu, SC; Zhan, LF | 1 |
| Deng, LJ; Lin, NJ; Liu, WP; Ping, LY; Song, YQ; Tu, MF; Wang, XJ; Wang, XP; Xie, Y; Yang, Z; Ying, ZT; Zhang, C; Zheng, W; Zhu, J | 2 |
| Augeul-Meunier, K; Bodet-Milin, C; Dupas, B; Frampas, E; Gastinne, T; Le Gouill, S | 1 |
| Carrasco, JL; Fuertes, S; Lopez-Guillermo, A; Pons, F; Rodríguez, S; Rovira, J; Setoain, X | 1 |
| Chung, JS; Lee, GW; Lee, HS; Lee, SE; Lee, SM; Oh, MY; Shin, HJ; Song, MK | 1 |
| Fujita, K; Hoshino, A; Itoh, K; Kawada, E; Kogure, T; Mantani, N; Sakamoto, H; Tamura, J; Ukita, T | 1 |
| Biancari, F; Biffoni, M; Marchesi, M | 1 |
| Bloom, DA; Chander, S; Getzen, TM; Joyrich, RN; Zak, IT; Zingas, AP | 1 |
| Alavi, A; Bhargava, P; Kumar, R; Schuster, SJ; Yu, JQ; Zhuang, H | 1 |
| Chang, CP; Chu, YK; Hsieh, HJ; Lin, SH; Liu, RS | 1 |
| Cohen, AM; Even-Sapir, E; Kanter, P; Marmelstein, V; Metser, U; Stein, GY; Streifler, J; Zeidman, A | 1 |
| Kim, EK; Kim, MJ; Oh, KK; Park, SY; Yun, M | 1 |
| Becherer, A; Hauswirth, A; Hoffmann, M; Jaeger, U; Kletter, K; Raderer, M; Turetschek, K; Wöhrer, S | 1 |
| De Renzo, A; Mainolfi, C; Pace, L; Perna, F; Persico, M | 1 |
| Kamisaki, Y; Kato, H; Matsunari, I; Murakami, J; Noguchi, K; Seto, H; Shimizu, M; Watanabe, N | 1 |
| Henderson, R; Iagaru, A | 1 |
| Coleman, M; Kostakoglu, L | 1 |
| Atasever, T; Chandramouly, A; Christos, P; Coleman, M; Furman, RR; Goldsmith, SJ; Kostakoglu, L; Kothari, P; Leonard, JP; Verma, S | 1 |
| Aoki, T; Asada, N; Matsue, K; Odawara, J; Ohuchi, T; Takeuchi, M; Yamakura, M | 1 |
| Besses, C; Calvo, N; Carrera, MJ; Conangla, M; Puget, G; Salar, A; Sitges-Serra, A; Trampal, C | 1 |
| Fields, P; Hofman, MS; Ireland, R; Mikhaeel, NG; Nunan, T; Yung, L | 1 |
| Hayasaka, K; Ishigaki, T; Ito, K; Itou, T; Kato, R; Nihashi, T; Okae, T | 1 |
| Hicks, RJ; Hogg, A; Januszewicz, H; Lee, M; Macmanus, M; Ng, AP; Prince, HM; Seymour, JF; Wirth, A; Wolf, M | 1 |
| Brière, J; Copie-Bergman, C; Dupuis, J; El Gnaoui, T; Gaillard, I; Gaulard, P; Gisselbrecht, C; Haioun, C; Hemery, F; Itti, E; Meignan, M; Rahmouni, A | 1 |
| Forman, S; Kirschbaum, MH; Rotter, A; Weiss, L; Zain, J | 1 |
| Hofmeyr, A; Lau, WF; Slavin, MA | 1 |
| Al-Nahhas, A; Banti, E; Bianchini, E; D'Andrea, E; Muzzio, PC; Paolini, R; Rubello, D | 1 |
| Brepoels, L; De Wever, W; De Wolf-Peeters, C; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Uyttebroeck, A; Vandenberghe, P; Verhoef, G | 1 |
| Amrein, PC; Hales, CA; Kradin, RL; Meyer, GS; Sharma, A | 1 |
| Specht, L | 1 |
| Chu, J; Kilanowska, J; Lin, M; Taper, J | 1 |
| Klabusay, M | 1 |
| Belohlávek, O; Klener, P; Koren, J; Pytlík, R; Sálková, J; Trnený, M | 1 |
| Chen, WL; Ho, CL | 1 |
| Minato, M; Takahashi, T; Tsujisaki, M; Tsukuda, H; Yoshimoto, M | 1 |
| Iwata, Y; Kinoshita, T; Kosugi, H; Koyama, Y; Nakamura, S; Naoe, T; Narimatsu, H; Nishibori, H; Shimada, K; Shimada, S; Suzuki, N; Yuge, M | 1 |
| Arimizu, N; Imazeki, K; Itami, J; Kuyama, J; Maruno, H; Minoshima, S; Okada, J; Uno, K; Yoshikawa, K | 1 |
44 review(s) available for fluorodeoxyglucose f18 and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Pre-treatment total metabolic tumour volumes in lymphoma: Does quantity matter?
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
Methodological Aspects and the Prognostic Value of Metabolic Tumor Volume assessed with 18F-FDG PET/CT in Lymphomas.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Biomarkers; Brain Ischemia; Brazil; Cardio-Renal Syndrome; Cholestasis, Intrahepatic; Colorectal Neoplasms; Cyclin-Dependent Kinase 8; Cytomegalovirus; Cytomegalovirus Infections; Drug Design; Female; Fluorides; Fluorine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Ganciclovir; Glutamates; Heart; Hematopoietic Stem Cell Transplantation; Heterografts; HIV Infections; Humans; Inflammation; Ischemia; Kidney; Lower Extremity; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Positron-Emission Tomography; Potassium Channels; Pregnancy; Pregnancy Complications; Prognosis; Prospective Studies; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Retrospective Studies; Sodium; Stem Cell Transplantation; Stroke; Structure-Activity Relationship; Systole; Tetraethylammonium; Tissue Distribution; Transplantation, Autologous; Varicose Veins; Vena Cava, Inferior | 2023 |
Prognostic factors in primary central nervous system lymphoma.
Topics: Artificial Intelligence; Biological Products; Biomarkers; Central Nervous System; Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Interleukin-10; Lymphoma, Large B-Cell, Diffuse; Prognosis | 2022 |
Diffuse Large B-Cell Lymphoma with pseudo Rosettes, A Rare Entity: Case Report with Literature Review.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Lymphoma, Large B-Cell, Diffuse; Rosette Formation | 2023 |
Interim FDG-PET/CT for Response Assessment of Lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis | 2023 |
Diffuse large B cell lymphoma in a preceding IgG4-related disease with kidney restricted lambda light chain expression: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunoglobulin lambda-Chains; Immunosuppressive Agents; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Missed Diagnosis; Nephritis, Interstitial; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Renal Insufficiency, Chronic | 2020 |
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography | 2021 |
Baseline PET/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Treatment Outcome; Tumor Burden | 2021 |
[FDG PET/CT FOR TREATMENT RESPONSE ASSESSMENT IN CANCER].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Tomography, X-Ray Computed | 2021 |
Interim PET-driven strategy in de novo diffuse large B-cell lymphoma: do we trust the driver?
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Time Factors | 2017 |
[Role of Interim 18
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis; Rituximab | 2017 |
An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
FDG-PET/CT in the management of lymphomas: current status and future directions.
Topics: Biopsy; Bone Marrow; Cell Transformation, Neoplastic; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome; Tumor Burden | 2018 |
Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2019 |
Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Prognosis; Progression-Free Survival; Proportional Hazards Models; Radiopharmaceuticals; Tumor Burden; Vincristine | 2019 |
End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma.
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome | 2019 |
The role of FDG-PET in the interim evaluation of therapy response in diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2013 |
FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
The predictive value of interim and final [18F] fluorodeoxyglucose positron emission tomography after rituximab-chemotherapy in the treatment of non-Hodgkin's lymphoma: a meta-analysis.
Topics: Antibodies, Monoclonal, Murine-Derived; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Proportional Hazards Models; Publication Bias; Rituximab | 2013 |
Role of PET in lymphoma.
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiotherapy, Conformal; Sensitivity and Specificity; Treatment Outcome | 2014 |
FDG-PET/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: case report and review of literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Cough; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lung; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Thyroid Gland; Tissue Distribution; Tomography, X-Ray Computed; Transplantation, Autologous; Vascular Neoplasms | 2015 |
Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Current status of the role of PET imaging in diffuse large B-cell lymphoma.
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Prognosis; Remission Induction; Rituximab; Treatment Outcome; Vincristine | 2015 |
Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.
Topics: Biological Transport; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2015 |
PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Survival Rate; Tomography, X-Ray Computed | 2016 |
Functional Imaging Using 18-Fluorodeoxyglucose PET in the Management of Primary Mediastinal Large B-Cell Lymphoma: The Contributions of the International Extranodal Lymphoma Study Group.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2016 |
[The role of PET/CT investigation in the management of patients with diffuse large B-cell lymphoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
[Recent advances in the understanding and treatment of diffuse large B-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Molecular Targeted Therapy; Mutation; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine | 2016 |
Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: Systematic review and meta-analysis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Vincristine | 2016 |
18F-FDG PET/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
FDG-PET for Early Response Assessment in Lymphomas: Part 2-Diffuse Large B-Cell Lymphoma, Use of Quantitative PET Evaluation.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Tumor Burden | 2017 |
Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review.
Topics: Adolescent; Adult; Child; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2009 |
Diffuse large B-cell lymphoma with massive portal vein tumor thrombosis in a patient with alcoholic cirrhosis: a case report and literature review.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis, Alcoholic; Lymphoma, Large B-Cell, Diffuse; Male; Neoplastic Cells, Circulating; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Spermatic Cord; Tomography, X-Ray Computed; Venous Thrombosis | 2009 |
Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now?
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Outcome Assessment, Health Care; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2009 |
An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2010 |
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Patient Selection; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Salvage Therapy; Treatment Outcome; Young Adult | 2010 |
Expression of glucose transporter-1, hypoxia-inducible factor-1α, phosphatidylinositol 3-kinase and protein kinase B (Akt) in relation to [(18)F]fluorodeoxyglucose uptake in nasopharyngeal diffuse large B-cell lymphoma: a case report and literature review
Topics: Adult; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Nasopharyngeal Neoplasms; Nasopharynx; Phosphatidylinositol 3-Kinase; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Tomography, X-Ray Computed | 2010 |
Personalized treatment of lymphoma: promise and reality.
Topics: Cancer Vaccines; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Positron-Emission Tomography; Precision Medicine | 2011 |
Are we ready for positron emission tomography/computed tomography-based target volume definition in lymphoma radiation therapy?
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Early interim PET scans in diffuse large B-cell lymphoma: can there be consensus about standardized reporting, and can PET scans guide therapy choices?
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reference Values; Risk Assessment | 2012 |
28 trial(s) available for fluorodeoxyglucose f18 and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Rituximab | 2022 |
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial.
Topics: Fluorodeoxyglucose F18; Germ Cells; Glucose; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Rituximab; Vincristine | 2022 |
Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nomograms; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen; Retrospective Studies; T-Lymphocytes | 2023 |
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Progression-Free Survival; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Rituximab; Vincristine; Young Adult | 2020 |
FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Prospective Studies; Rituximab; United Kingdom; Vincristine; Young Adult | 2021 |
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study.
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies; Salvage Therapy | 2022 |
Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2017 |
Evaluation of diffuse large B-cell lymphoma patients with 64-slice multidetector computed tomography versus
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Single-Blind Method | 2018 |
Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Filgrastim; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Polyethylene Glycols; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Recombinant Proteins; Recurrence; Rituximab; Tomography, X-Ray Computed; Treatment Failure; Vincristine; Young Adult | 2013 |
Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2014 |
[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Radiopharmaceuticals; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2014 |
Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Transplantation, Autologous; Treatment Outcome; Vincristine | 2014 |
Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prospective Studies; Rituximab; Vincristine; Young Adult | 2015 |
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2015 |
Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.
Topics: Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Time Factors; Vincristine | 2016 |
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Positron-Emission Tomography; Prednisone; Retreatment; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2017 |
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Vincristine | 2008 |
Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; France; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome; Young Adult | 2009 |
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Education, Medical, Continuing; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Nuclear Medicine; Observer Variation; Positron-Emission Tomography; Prednisone; Reproducibility of Results; Rituximab; Vincristine | 2010 |
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Child; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; HIV; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Viral Load; Young Adult | 2010 |
Pitfalls of interim positron emission tomography scanning in diffuse large B-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Time Factors; Treatment Outcome | 2010 |
Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background.
Topics: Antineoplastic Agents; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Liver; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2010 |
Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography.
Topics: Abdomen; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2011 |
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Rituximab; Vincristine; Vindesine | 2011 |
Pre-transplant (18)F-fluorodeoxyglucose positron emission tomography-based survival model in patients with aggressive lymphoma undergoing high-dose chemotherapy and autologous SCT.
Topics: Adolescent; Adult; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Models, Biological; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Risk Factors; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2013 |
458 other study(ies) available for fluorodeoxyglucose f18 and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements.
Topics: Fluorodeoxyglucose F18; Gene Rearrangement; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2022 |
[
Topics: Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies | 2022 |
A Case of Diffuse Large B-cell Lymphoma with Cardiac Involvement Incidently Diagnosed on Cardiac Imaging.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Malignant Lymphoma Diagnosed as Gallbladder Carcinoma on 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Assessing bone marrow involvement in diffuse large B-cell lymphoma with 18F-FDG PET/CT: A preliminary experience at Hospital Pulau Pinang.
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Hospitals; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS.
Topics: Brain; Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Chimeric Antigen | 2022 |
Biopsy, as Deauville May Deceive.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography | 2021 |
PET/CT Responses in Primary Mediastinal Large B-Cell Lymphoma: What's Negative?
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Body CT and PET/CT detection of extracranial lymphoma in patients with newly diagnosed central nervous system lymphoma.
Topics: Central Nervous System; Cohort Studies; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
[Role of FDG-PET/CT in diffuse large B-cell lymphoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography | 2021 |
The prognostic value of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: comparison of visual Deauville criteria and a lesion-to-liver SUV
Topics: Fluorodeoxyglucose F18; Humans; Liver; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Research Design; Retrospective Studies | 2022 |
Risk of Upstaging Due to Oncofertility Treatment Mimicking Pelvic Lymphoma on 18F-FDG PET/CT.
Topics: Adult; Female; Fertility Preservation; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Young Adult | 2022 |
Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Receptors, Chimeric Antigen | 2022 |
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2022 |
Lumbosacral Plexus Neurolymphomatosis: A Typical 18FDG PET/CT Pattern to Recognize.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lumbosacral Plexus; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Neurolymphomatosis; Positron Emission Tomography Computed Tomography | 2022 |
Richter's transformation with isolated cardiac involvement diagnosed by 2-[
Topics: Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Rapid deterioration of intravascular large B-cell lymphoma with mass formation in the trigeminal nerve and multiple organ infiltration: An autopsy case report.
Topics: Autopsy; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Trigeminal Nerve | 2022 |
[Systemic sarcoidosis developed after chemoradiotherapy for localized thyroid diffuse large B-cell lymphoma].
Topics: Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis; Thyroid Gland | 2021 |
Using 18F-FDG PET/CT to rule out Richter transformation as cause of deterioration in a patient with chronic lymphatic leukemia and severe COVID-19: A case report.
Topics: Clinical Deterioration; COVID-19; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Lymphoma presented as dysphagia: a diagnosis hard to swallow.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deglutition Disorders; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine | 2021 |
Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow Examination; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Gene Rearrangement, B-Lymphocyte, Light Chain; Humans; Immunoglobulin Heavy Chains; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Young Adult | 2022 |
Prognostic significance of clinical characteristics and
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Vincristine; Young Adult | 2022 |
Primary Breast Lymphoma Detected by 18F-FDG and 68Ga-DOTA-FAPI-04 PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Foreign Body Granuloma Masquerading as Remnant Lymphoma on 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Mitoxantrone; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisolone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2021 |
Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Prognosis; Progression-Free Survival; Retrospective Studies | 2022 |
A rare case of Diffuse Large B-Cell Lymphoma of the Prostate on 18F-FDG PET-CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate; Radiopharmaceuticals | 2021 |
Deep learning-based tumour segmentation and total metabolic tumour volume prediction in the prognosis of diffuse large B-cell lymphoma patients in 3D FDG-PET images.
Topics: Deep Learning; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
A comparison of FDG PET/MR and PET/CT for staging, response assessment, and prognostic imaging biomarkers in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results | 2022 |
18F-FDG PET/CT Findings in HIV-Positive Patient With Primary Pancreas Lymphoma and CMV Pancreatitis.
Topics: Adult; Cytomegalovirus Infections; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Pancreas; Pancreatitis; Positron Emission Tomography Computed Tomography | 2022 |
Radiomics signature from [
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2022 |
Unusual Illustration of Richter Transformation in Chronic Lymphocytic Leukemia on FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
[18F-fluorothymidine preclinical study in non-human primate. Dosimetry and biodistribution].
Topics: Animals; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Primates; Radiometry; Radiopharmaceuticals; Tissue Distribution | 2022 |
The Central Cavitation in Pulmonary Diffuse Large B-Cell Lymphoma Detected by 18F-FDG PET/CT.
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Diffuse
Topics: Aged; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
PET/CT imaging of renal intravascular large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments.
Topics: Artificial Intelligence; Automation; Clinical Trials, Phase III as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Risk Assessment; Tumor Burden | 2022 |
Multimodal deep learning model on interim [
Topics: Deep Learning; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Failure | 2023 |
SMYD3 promotes aerobic glycolysis in diffuse large B-cell lymphoma via H3K4me3-mediated PKM2 transcription.
Topics: Carrier Proteins; Fluorodeoxyglucose F18; Glycolysis; Histone-Lysine N-Methyltransferase; Histones; Humans; Lymphoma, Large B-Cell, Diffuse; Membrane Proteins; Positron Emission Tomography Computed Tomography; Pyruvate Kinase; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy.
Topics: Adult; Aged; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prednisolone; Prognosis; Radioimmunotherapy; Retrospective Studies; Rituximab; Vincristine | 2022 |
[The Prognosis Assessment Value of Interim
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2022 |
Searing abdomen: Infrequent presentation of peritoneal lymphomatosis in Diffuse Large B-Cell Lymphoma on 18F-FDG PET-CT scan.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Peritoneum; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Evaluation of the Effects of R-CHOP Chemotherapy on Brain Glucose Metabolism in Patients with Diffuse Large B Cell Lymphoma: A Baseline, Interim, and End-of-Treatment PET/CT Study.
Topics: Antibodies, Monoclonal, Murine-Derived; Brain; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Glucose; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Tomography, X-Ray Computed; Vincristine | 2022 |
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Receptors, Chimeric Antigen; Retrospective Studies; T-Lymphocytes | 2023 |
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Potential Role of 68Ga-NOTA-Duramycin PET/CT Imaging for Early Response Evaluation in a Lymphoma Patient: A Case Report.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peptides; Phosphatidylethanolamines; Positron Emission Tomography Computed Tomography | 2023 |
Neurexin-3α-associated autoimmune encephalitis with intracranial diffuse large B lymphoma diagnosed on FDG and TSPO PET/MRI.
Topics: Autoimmune Diseases of the Nervous System; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA | 2023 |
Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy.
Topics: Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies | 2023 |
Influence of the methodological aspects of the dichotomization of total metabolic tumor volume measured through baseline fluorine-18 fluorodeoxyglucose PET on survival prediction in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2023 |
Development and validation of a [
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Evaluation of a convolution neural network for baseline total tumor metabolic volume on [
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Large B-Cell, Diffuse; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Tumor Burden | 2023 |
Early Hyperprogression of Lymphoma Detected by 18 F-FDG PET/CT After Chimeric Antigen Receptor T-Cell Therapy.
Topics: Aged; Cell- and Tissue-Based Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen | 2023 |
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.
Topics: Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Receptors, Chimeric Antigen | 2023 |
Iterated cross validation method for prediction of survival in diffuse large B-cell lymphoma for small size dataset.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Rituximab | 2023 |
Prognostic parameters on baseline and interim [ 18 F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients.
Topics: Body Weight; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2023 |
18 F-THK5351 PET Can Evaluate Tumor Extension in Intravascular Large B-Cell Lymphoma : Comparison With 11C-Methionine PET and 18F-FDG PET.
Topics: Aged; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2023 |
The prognostic value of splenic abnormalities in pretreatment
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Splenic Diseases; Splenomegaly | 2023 |
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL.
Topics: Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Retrospective Studies | 2023 |
Prognostic value of interim
Topics: Adult; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2023 |
Bayesian penalized likelihood PET reconstruction impact on quantitative metrics in diffuse large B-cell lymphoma.
Topics: Algorithms; Bayes Theorem; Benchmarking; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2023 |
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Risk Factors | 2023 |
Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation?
Topics: Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Retrospective Studies; Transplantation, Autologous | 2023 |
Intravascular Large B-Cell Lymphoma Identified by PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Prognostic value of metabolic tumor volume and lesion dissemination from baseline PET/CT in patients with diffuse large B-cell lymphoma: Further risk stratification of the group with low-risk and high-risk NCCN-IPI.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Tumor Burden | 2023 |
Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort.
Topics: Artificial Intelligence; Circulating Tumor DNA; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2023 |
Interim PET in follicular lymphoma: more patience, please.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2023 |
Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era.
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Primary Malignant Lymphoma of the Cauda Equina Diagnosed after Decompression for Lumbar Spinal Stenosis: A Case Report.
Topics: Activities of Daily Living; Aged, 80 and over; Cauda Equina; Decompression; Fluorodeoxyglucose F18; Gadolinium; Humans; Lumbar Vertebrae; Lymphoma, Large B-Cell, Diffuse; Male; Muscle Weakness; Spinal Stenosis | 2023 |
A nomogram for predicting the rapid progression of diffuse large B-cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 mutations.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Mutation; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden; Tumor Suppressor Protein p53 | 2023 |
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by
Topics: Antigens, CD19; Biomarkers; Clinical Decision-Making; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen; Retrospective Studies; Uncertainty | 2023 |
Prediction of lymphoma response to CAR T cells by deep learning-based image analysis.
Topics: Adult; Deep Learning; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; T-Lymphocytes; Treatment Outcome | 2023 |
Primary Pancreatic Lymphoma Masquerading as Carcinoma on 18 F-FDG PET/CT.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Stacking Ensemble Learning-Based [
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Machine Learning; Prognosis; Reproducibility of Results | 2023 |
A retrospective head-to-head comparison of the Lugano classification and PERCIST for FDG-PET/CT response assessment in diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2024 |
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Lymphoma, Large B-Cell, Diffuse; Paraproteinemias; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies | 2023 |
Robust deep learning-based PET prognostic imaging biomarker for DLBCL patients: a multicenter study.
Topics: Biomarkers; Deep Learning; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2023 |
Complete Absence of FAPI Uptake in a Patient With Aggressive Diffuse Large B-Cell Lymphoma Involving Multiple Nodal and Extranodal Sites.
Topics: Aged; Biological Transport; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Extramedullary Hematopoiesis in Treated Diffuse Large B-Cell Lymphoma of Bone.
Topics: Aged; Fluorodeoxyglucose F18; Hematopoiesis, Extramedullary; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcome.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Risk Factors | 2023 |
Vincristine-induced Polyneuropathy at FDG PET/CT.
Topics: Antineoplastic Agents, Phytogenic; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Polyneuropathies; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vincristine; Whole Body Imaging | 2019 |
Intravascular Large B-Cell Lymphoma Presenting with Hypoxemia without any Abnormalities on Standard Imaging Studies.
Topics: Aged; Biopsy; Dyspnea; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography | 2019 |
The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Propensity Score; Republic of Korea; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2020 |
[Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Vascular Neoplasms; Vincristine | 2019 |
Magnetic resonance imaging and
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Neurolymphomatosis; Positron Emission Tomography Computed Tomography | 2020 |
A Rare Case of Primary Ventricular Lymphoma Presented on FDG PET/CT.
Topics: Cerebral Ventricle Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Lymphoma Recurrence Along the Lymphatic Tract on 18F-FDG PET/CT Presenting as Lower Limb Swelling.
Topics: Aged; Diagnosis, Differential; Edema; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Vessels; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thigh | 2020 |
Prognostic Value of Baseline Total Metabolic Tumor Volume Measured on FDG PET in Patients With Richter Syndrome.
Topics: Adult; Aged; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Tumor Burden | 2020 |
An Uncommon Initial Presentation of T-Cell/Histiocyte-Rich B-Cell Lymphoma: Acute Renal Failure.
Topics: Acute Kidney Injury; Adult; Fluorodeoxyglucose F18; Histiocytes; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; T-Lymphocytes | 2020 |
Extranodal involvement of multiple organs in diffuse large B cell lymphoma detected on
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
"Hot Lung" Sign in Pulmonary Intravascular Large B-Cell Lymphoma on 18F-FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Autografts; Bone Marrow; Chromosome Aberrations; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Rituximab; Survival Rate; Vincristine | 2020 |
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the diagnosis and follow-up of primary hepatic diffuse large B-cell Lymphoma: A clinical case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
18F-FDG PET/CT Finding of Primary Cardiac Lymphoma.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
To evaluate prognostic significance of metabolic-derived tumour volume at staging 18-flurodeoxyglucose PET-CT scan and to compare it with standardized uptake value-based response evaluation on interim 18-flurodeoxyglucose PET-CT scan in patients of non-Ho
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve; Tumor Burden; Young Adult | 2020 |
Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2020 |
18F-FDG PET/CT demonstrated symmetric FDG uptake in internal capsule in a diffuse large B cell lymphoma patient with false interpretation on multiparametric brain MRI.
Topics: Fluorodeoxyglucose F18; Humans; Internal Capsule; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
18FDG PET/CT in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Rituximab; Skin Neoplasms; Treatment Outcome | 2020 |
Baseline
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden; Young Adult | 2020 |
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Genetic Heterogeneity; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Vanishing Bone Metastases in 18F-FDG PET/CT.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Thoracic Vertebrae | 2020 |
Posttreatment FDG-Avid Splenic Lesions in DLBCL and HD: Clinical and Radiographic Characteristics for Risk Assessment.
Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Risk Assessment; Spleen | 2020 |
Primary bone lymphoma of the thoracic vertebra in a patient with metastatic lung cancer.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Vertebrae | 2020 |
High metabolic heterogeneity on baseline 18FDG-PET/CT scan as a poor prognostic factor for newly diagnosed diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Tumor Microenvironment | 2020 |
Atypical Presentation of COVID-19 Incidentally Detected at 18F-FDG PET/CT in an Asymptomatic Oncological Patient.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; SARS-CoV-2 | 2020 |
ΔSUVmax for interim PET in DLBCL: old is new.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis | 2020 |
Cutaneous Metastases from Testicular Diffuse Large B-cell Malignant Lymphoma and Bowen Disease: 18F-FDG PET-CT Findings.
Topics: Bowen's Disease; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Radiopharmaceuticals; Skin Neoplasms; Testicular Neoplasms | 2020 |
Excellent Interim Treatment Response with Polatuzumab Vedotin
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Fluorodeoxyglucose F18; Humans; Immunoconjugates; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Molecular Targeted Therapy; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2020 |
The evolving definition of bulky disease for lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis | 2020 |
Primary Pancreatic Lymphoma on FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
Comparison of the prognostic values of
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Colonic Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden | 2020 |
Primary hepatic diffuse large B-cell lymphoma presenting unusual imaging features.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2020 |
[Roles of PET/CT in Predicting the Prognosis of Diffuse Large B Cell Lymphoma Patients Treated with Chimeric Antigen Receptor T Cell Therapy].
Topics: Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies | 2020 |
Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on
Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma | 2021 |
Progression Free Survival and Predictor of Recurrence in DLBCL patients with Negative Interim 18FDG PET/CT Using Standardized Imaging and Reporting Protocols.
Topics: Adult; Aged; Aged, 80 and over; Documentation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Progression-Free Survival; Prospective Studies; Radiopharmaceuticals; ROC Curve; Survival Rate; Young Adult | 2020 |
Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy, Adjuvant; Radiotherapy, Image-Guided; Retrospective Studies; Rituximab; Single-Blind Method; Treatment Outcome; Tumor Burden; Vincristine; Young Adult | 2021 |
Prognostic value of the baseline 18F-FDG PET/CT metabolic tumour volume (MTV) and further stratification in low-intermediate (L-I) and high-intermediate (H-I) risk NCCNIPI subgroup by MTV in DLBCL MTV predict prognosis in DLBCL.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Risk; ROC Curve; Tumor Burden | 2021 |
Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Muscle, Skeletal; Pancreatic Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms | 2020 |
The prognostic role of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: a pilot study application of neural networks to predict time-to-event.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neural Networks, Computer; Pilot Projects; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2021 |
The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Spleen; Tumor Burden | 2021 |
Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Prospective Studies; Reproducibility of Results; Retrospective Studies; Tumor Burden | 2021 |
The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor.
Topics: Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Receptors, Antigen, B-Cell | 2020 |
Research on the midterm efficacy and prognosis of patients with diffuse large B-cell lymphoma by different evaluation methods in interim PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2020 |
Topics: Adult; Antigens, CD19; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen; Recurrence; Treatment Failure | 2021 |
Interim PET in Diffuse Large B-Cell Lymphoma.
Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Risk Assessment; Tumor Burden | 2021 |
Testicular FDG-PET/CT uptake threshold in aggressive lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Burkitt Lymphoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Testis; Young Adult | 2021 |
The diagnosis of a giant cardiac malignant lymphoma in the right ventricle: a case report.
Topics: Aged; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography | 2021 |
Hypermetabolic bilateral kidney enlargement associated with diffuse large B-cell lymphoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Diseases; Lymphoma, Large B-Cell, Diffuse | 2021 |
PET response-guided radiotherapy for advanced DLBCL?
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Vincristine | 2021 |
Evaluation of the prognostic utility of bone marrow biopsy in diffuse large B-Cell lymphoma in the SEER-Medicare dataset.
Topics: Aged; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Medicare; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; United States | 2021 |
The value of 18F-FDG PET/CT in evaluating the efficacy of chemotherapy for diffuse large B-cell lymphoma with cardiac involvement.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
[The 485th case: fever of undetermined origin and hypoxemia].
Topics: Fluorodeoxyglucose F18; Humans; Hypoxia; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2021 |
Improved prediction of chemoresistance in patients with diffuse large B-cell lymphoma through a new interim positron emission tomography-computed tomography evaluation model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2021 |
Deauville score evaluation of interim PET/CT in primary mediastinal large B-cell lymphoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Thymus Neoplasms | 2021 |
Prognostic significance of bone marrow 2-[
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2021 |
FDG PET/CT Showing a Primary Lymphoma of the Sternoclavicular Joint.
Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Sternoclavicular Joint | 2021 |
Not Yet Time to Abandon the Deauville Criteria in Diffuse Large B-Cell Lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse | 2021 |
Mediastinal diffuse large B-cell lymphoma mimicking invasive thymoma on
Topics: Adult; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Thymoma; Thymus Neoplasms | 2022 |
Lymphoma involving the brain and adrenals: A chicken and egg situation.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Vincristine | 2021 |
18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Progression-Free Survival | 2021 |
Are treatment response assessment maps (TRAMs) and
Topics: Central Nervous System Neoplasms; Cerebellar Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Multimodal Imaging; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
End-of-treatment
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2021 |
Topics: Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptors, Chimeric Antigen; Retrospective Studies | 2021 |
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2021 |
Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Retrospective Studies; Rituximab; ROC Curve; Time Factors; Tumor Burden; Vincristine | 2021 |
Orbital Plasmablastic Lymphoma: A Rare Variant of Diffuse Large B-Cell Lymphoma Staged and Followed Up by 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Plasmablastic Lymphoma; Positron Emission Tomography Computed Tomography | 2022 |
Very delayed sinus arrest during complete remission of diffuse large B-cell lymphoma invading right atrium.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bradycardia; Cyclophosphamide; Doxorubicin; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Prednisone; Remission Induction; Rituximab; Sinus Arrest, Cardiac; Uterine Neoplasms; Vincristine | 2021 |
Primary cardiac lymphoma: the management and outcome of a single-centre cohort of 22 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Retrospective Studies | 2021 |
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2022 |
Prognostic value of presalvage metabolic tumor volume in patients with relapsed/refractory diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
Distal appendicular skeletal involvement of diffuse large B-cell lymphoma on technetium-99m methylenediphosphonate bone scintigraphy and
Topics: Aged; Bone Neoplasms; Diphosphonates; Fluorodeoxyglucose F18; Gingivitis; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Maxilla; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Skin Neoplasms; Testicular Neoplasms; Tooth Extraction; Treatment Outcome; Whole Body Imaging | 2017 |
18F-FDG-PET/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis.
Topics: Aged; Bone Marrow; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mutation; Positron Emission Tomography Computed Tomography; Primary Myelofibrosis | 2017 |
Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Topics: Adult; Aged; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Richter Syndrome With Extensive Isolated Pleural Extranodal Involvement: The Importance of PET/CT Imaging.
Topics: Aged; Cell Transformation, Neoplastic; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Syndrome | 2017 |
[Values of Different Evaluation Criteria of Interim
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2016 |
Stensen Duct Relapse of Diffuse Large B-Cell Lymphoma: An Unusual Pattern Detected With 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Parotid Gland; Positron Emission Tomography Computed Tomography; Recurrence | 2017 |
Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Reference Values; Rituximab; Sensitivity and Specificity; Treatment Outcome; Vincristine | 2018 |
Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Survival Analysis; Young Adult | 2017 |
18F-FDG PET/CT Scan Can Predate Clinical Presentation in Acute Appendicitis.
Topics: Acute Disease; Appendicitis; Biological Transport; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2017 |
Imaging features of primary cardiac lymphoma.
Topics: Aged; Echocardiography, Transesophageal; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Cell Transformation, Neoplastic; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Waldenstrom Macroglobulinemia | 2017 |
A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDG PET images.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2017 |
Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.
Topics: Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred C57BL; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Transplantation, Autologous | 2018 |
High-risk DLBCL: interim PET? Not yet.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2017 |
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2018 |
Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2018 |
Diagnosis of extensive myocardial infiltration by diffuse large B-cell lymphoma using 18F-fluorodeoxyglucose positron emission tomography (18-FDG PET).
Topics: Aged; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Tumor and bone marrow uptakes on [18F]fluorodeoxyglucose positron emission tomography/computed tomography predict prognosis in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Rituximab; Whole Body Imaging; Young Adult | 2017 |
Interim 18F-FDG PET/CT and BCL2 for predicting the prognosis of patients with diffuse large B-cell lymphoma in the rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Rituximab; Young Adult | 2018 |
Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2018 |
Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients?
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Survival Analysis; Young Adult | 2018 |
Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Transcriptome; Tumor Burden | 2018 |
Rare Variant of Intravascular Large B-Cell Lymphoma With Hemophagocytic Syndrome.
Topics: Fluorodeoxyglucose F18; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Vascular Neoplasms | 2018 |
Interim FDG PET/CT in primary mediastinal diffuse large B-cell lymphoma: really almost useless procedure?
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2018 |
Reply: Interim FDG-PET/CT in primary mediastinal diffuse large B-cell lymphoma: really almost useless procedure?
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2018 |
Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2018 |
Costs and clinical outcomes of patients with diffuse large B-cell lymphoma in first remission: role of PET/CT surveillance.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Time Factors; Young Adult | 2019 |
Prognostic significance of retention index of bone marrow on dual-phase 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Bone Marrow; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Survival Analysis; Young Adult | 2018 |
Unusually Elevated Gastric Radioactivity on 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach | 2018 |
Challenges of assessing response to therapy in non-Hodgkin's lymphoma of the bone.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Humeral Head; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Osteonecrosis; Positron Emission Tomography Computed Tomography; Remission Induction; Treatment Outcome | 2018 |
Newly Diagnosed Primary Gum Lymphoma on FDG PET/CT.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gingiva; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
High 18F-fluorodeoxyglucose uptake in primary bilateral adrenal diffuse large B-cell lymphomas with nongerminal center B-cell phenotype: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Prednisone; Vincristine; Young Adult | 2018 |
Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; ROC Curve; Tumor Burden | 2018 |
Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?
Topics: Adult; Child; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Tumor Burden | 2018 |
Galactocele, Pitfall for the Evaluation by 18F-FDG PET/CT.
Topics: Adult; Breast Cyst; Breast Feeding; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma.
Topics: Adult; Aged; Carbon Radioisotopes; Central Nervous System Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methionine; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Simultaneous breast cancer and DLBCL lymphoma - role of PET/CT examination with 18F-FDG and 18F-FES.
Topics: Aged; Breast Neoplasms; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography | 2018 |
Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CD5 Antigens; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Nasal Cavity; Nose Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Treatment Outcome; Vascular Neoplasms | 2018 |
Multiple Subcutaneous Nodules as Initial Presentation of Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL) Detected by PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2018 |
[Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden | 2018 |
CT and
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
Extreme exigency in the extremity: an illustrative case of diffuse large B-cell lymphoma occurring in the arm.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Flow Cytometry; Fluorodeoxyglucose F18; Forearm; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine | 2018 |
Asymmetrical and Isolated Hypoglossal Nerve Palsy Accompanied by a New Subset of Anti-ganglioside Antibodies in a Patient with Diffuse Large B Cell Lymphoma.
Topics: Aged; Fluorodeoxyglucose F18; G(M1) Ganglioside; Globosides; Humans; Hypoglossal Nerve Diseases; Immunoglobulin M; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2019 |
PET/CT Imaging for Solitary Primary Bone Lymphoma of Thoracic Vertebra.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Vertebrae | 2018 |
[Value of
Topics: B-Lymphocytes; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2018 |
18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer.
Topics: Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2018 |
Unexpected Corpus Callosum Involvement of Diffuse Large B-Cell Lymphoma on FDG PET/CT.
Topics: Aged; Corpus Callosum; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?
Topics: Adult; Child; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Tumor Burden | 2019 |
Richter Syndrome Presenting With Colon Localization.
Topics: Aged; Biopsy; Cell Transformation, Neoplastic; Colon; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography | 2019 |
Diffuse Large B-Cell Lymphoma Recurring as Neurolymphomatosis on FDG PET/CT.
Topics: Aged, 80 and over; Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neurolymphomatosis; Positron Emission Tomography Computed Tomography; Recurrence | 2019 |
The prognostic role of end of treatment FDG-PET-CT in patients with diffuse large B cell lymphoma can be improved by considering it with absolute monocyte count at diagnosis.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Leukocyte Count; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Monocytes; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Treatment Outcome; Young Adult | 2019 |
PET-derived tumor metrics predict DLBCL response and progression-free survival.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; ROC Curve; Treatment Outcome; Vincristine; Young Adult | 2019 |
[Prognostic Value of Interim PET/CT in 227 Patients of DLBCL].
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-center experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Survival Analysis; Tumor Burden; Vincristine | 2021 |
High-grade B-cell lymphoma relapse presenting as neurolymphomatosis of the median nerve.
Topics: Aged; Arm; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Median Nerve; Neurolymphomatosis; Positron-Emission Tomography; Radiotherapy; Ultrasonography; Ultrasonography, Doppler, Duplex | 2019 |
Topics: Aged; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neurolymphomatosis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence | 2019 |
Spontaneous regression of diffuse large B-cell lymphoma in the small intestine with multiple lymphadenopathy.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Intestine, Small; Lymphadenopathy; Lymphocytes, Tumor-Infiltrating; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Remission, Spontaneous | 2019 |
Prognostic value of metabolic tumour volume on baseline
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; ROC Curve; Severity of Illness Index; Tumor Burden; Young Adult | 2019 |
Time to Prepare for Risk Adaptation in Lymphoma by Standardizing Measurement of Metabolic Tumor Burden.
Topics: Congresses as Topic; Diagnostic Imaging; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Medical Oncology; Positron-Emission Tomography; Prognosis; Reference Standards; Risk Assessment; Software; Tomography, X-Ray Computed; Tumor Burden | 2019 |
Designing optimal prognostic models for diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Monocytes; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
Tumour necrosis as assessed with
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gene Rearrangement, B-Lymphocyte; Genes, myc; Glycolysis; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tumor Burden | 2019 |
Role of interim and end of treatment positron emission tomography for response assessment and prediction of relapse in posttransplant lymphoproliferative disorder.
Topics: Adult; Aged; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Organ Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2019 |
[Sarcoidosis-lymphoma syndrome showing abnormal FDG uptake in lymph nodes and muscles upon post-chemotherapy PET/CT imaging].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2019 |
Eighty-nine-year-old woman with fatigue and reduced appetite.
Topics: Aged, 80 and over; Appetite Regulation; Fatigue; Feeding and Eating Disorders; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Pericardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
PET beyond Deauville in diffuse large B-cell lymphoma.
Topics: Benchmarking; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Progression-Free Survival | 2019 |
Comparing radioactive tracers 18F-FDG and 18F-FLT in the staging of diffuse large B-cell lymphoma by PET/CT examination: A single-center prospective study.
Topics: Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radioactive Tracers; Radiopharmaceuticals | 2019 |
Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Biomarkers; Data Analysis; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; ROC Curve; Tumor Burden; Young Adult | 2019 |
A better prediction of progression-free survival in diffuse large B-cell lymphoma by a prognostic model consisting of baseline TLG and %ΔSUV
Topics: Adolescent; Adult; Aged, 80 and over; Biomarkers; Child; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; ROC Curve; Tumor Burden; Young Adult | 2019 |
An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Peripheral Nerves; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Prognostic utility of pre-transplantation [
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Dexamethasone; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Rituximab; Salvage Therapy | 2020 |
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Vincristine | 2013 |
Predictive value of [¹⁸F]fluoro-2-deoxy-D-glucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiotherapy; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Young Adult | 2014 |
"Invisible" primary cutaneous diffuse large B-cell lymphoma, leg type, as a cause of fever of unknown origin.
Topics: Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Leg; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Multimodal Imaging; Radiographic Image Interpretation, Computer-Assisted; Radionuclide Imaging; Skin Neoplasms | 2013 |
Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy.
Topics: Adolescent; Adult; Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2014 |
An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.
Topics: Adult; Aged; Aged, 80 and over; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Imaging characteristics of cardiac dominant diffuse large B-cell lymphoma demonstrated with MDCT and PET/CT.
Topics: Adult; Aged; Case-Control Studies; Child; Coronary Angiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Pericardial Effusion; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation.
Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Young Adult | 2013 |
Relationship between 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Child; Female; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2014 |
Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
Topics: Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pleural Effusion, Malignant; Positron-Emission Tomography; Prednisone; Republic of Korea; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2014 |
Large vessel vasculopathy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carotid Artery, Common; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Vascular Diseases | 2014 |
Reply: Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
Topics: Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
[Correlation of ¹⁸F-FDG uptake with tumor-proliferating antigen Ki-67 expression in aggressive lymphoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2013 |
Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Positron emission tomography/computerized tomography in the evaluation of primary non-Hodgkin's lymphoma of prostate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prostatic Neoplasms; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
An unusual case of diffuse large B-cell lymphoma involving the vulva evaluated by 18F-FDG PET/CT.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vulva | 2014 |
Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDG.
Topics: Cell Dedifferentiation; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Child; Disease-Free Survival; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Transplantation, Autologous; Transplantation, Homologous | 2014 |
Transformation of follicular lymphoma in the retroperitoneal muscles demonstrated by CT-guided needle biopsy of FDG-avid lesions; case series.
Topics: Aged; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Rituximab; Tumor Burden; Vincristine | 2014 |
The rate of reduction in the maximum standardized uptake value from the initial to the post-R-CHOP therapy in positron emission tomography scan predicts disease progression in diffuse large B cell lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisolone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2014 |
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Interim and end-treatment positron emission tomography scan in aggressive B-cell lymphoma: we still lack an interpretation key.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Salvage Therapy; Tomography, X-Ray Computed; Vincristine; Young Adult | 2014 |
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Leg; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2014 |
Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Biopsy; Bone Marrow; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation.
Topics: Age Factors; Aged; Analysis of Variance; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rituximab; Sex Factors; Time Factors; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Vincristine | 2014 |
[Value of interim 18F-FDG PET-CT examination in evaluation of chemotherapy response and prognosis in patients with diffuse large B-cell lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Evolving treatment paradigms for primary mediastinal diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Radionuclide Imaging | 2014 |
PET/CT findings in a case with FDG-avid disseminated lacrimal gland MALToma with sequential development of large B-cell lymphoma and gastric MALToma.
Topics: Aged; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2014 |
Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Vincristine | 2014 |
[Significance of SUV value in pre-therapy FDG-PET/CT examination in patients with diffuse large B-cell lymphoma occurred primarily in cervical lymph nodes].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neck; Positron-Emission Tomography; Prognosis; Young Adult | 2014 |
Neurolymphomatosis exhibiting repeated exacerbation and remission in both the peripheral and central nervous systems.
Topics: Biopsy; Central Nervous System; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Middle Aged; Nervous System Neoplasms; Peripheral Nerves; Positron-Emission Tomography | 2014 |
Anti-erythropoietin receptor antibody-associated pure red cell aplasia accompanied by Coombs-negative autoimmune hemolytic anemia in a patient with T cell/histiocyte-rich large B cell lymphoma.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Histiocytes; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Receptors, Erythropoietin; Red-Cell Aplasia, Pure; T-Lymphocytes; Tomography, X-Ray Computed | 2014 |
Crossed cerebellar diaschisis due to cerebral diffuse large B cell lymphoma on 18F-FDG PET/CT.
Topics: Brain Neoplasms; Cerebellum; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
18F-FDG PET/CT demonstrating primary bone lymphoma of the extremities mimicking an inflammatory peripheral arthropathy.
Topics: Aged; Bone Neoplasms; Diagnosis, Differential; Extremities; Female; Fluorodeoxyglucose F18; Humans; Joint Diseases; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Brain Diseases; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Interleukin-10; Interleukin-6; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Interleukin-2; ROC Curve; Sensitivity and Specificity | 2015 |
Bone marrow biopsy in diffuse large B-cell lymphoma: useful or redundant test?
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Tomography, X-Ray Computed | 2015 |
Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Bone Marrow Examination; Contrast Media; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging | 2015 |
CD5- and CD23-positive splenic diffuse large B-cell lymphoma with very low CD20 expression.
Topics: Antigens, CD20; CD5 Antigens; Chromosome Aberrations; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Immunophenotyping; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Receptors, IgE; Splenic Neoplasms | 2014 |
(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Denmark; Female; Finland; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Norway; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Sweden; Tissue Distribution; Tomography, X-Ray Computed; United States; Young Adult | 2015 |
Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Ilium; Imaging, Three-Dimensional; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Fluorothymidine PET/CT in neurolymphomatosis.
Topics: Animals; Biopsy; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Marek Disease; Middle Aged; Multimodal Imaging; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sciatic Neuropathy; Tomography, X-Ray Computed | 2015 |
Non-Hodgkin lymphoma dominated by multiple organ extranodal disease revealed on FDG PET/CT.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Boronic Acids; Bortezomib; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Prednisone; Pyrazines; Treatment Outcome; Vincristine | 2015 |
[Prognostic value of PET-CT in patients with diffuse large B-cell lymphoma].
Topics: Adult; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography; Remission Induction; Retrospective Studies; Treatment Outcome | 2014 |
Utility of interim and end-of-treatment [(18)F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Prednisone; Proportional Hazards Models; Remission Induction; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Vincristine; Young Adult | 2015 |
Dysfunctional neobladder causing pulmonary toxicity after combination chemotherapy for lymphoma.
Topics: Acute Lung Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Kidney; Lung; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Renal Insufficiency; Urinary Bladder | 2015 |
[Research progress on 18F-FDG PET/CT in evaluating prognosis of patient with diffuse large B cell lymphoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2015 |
Diffuse thyroid 18F-FDG uptake after R-CHOP therapy predicts favorable outcome in patients with DLBCL.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Rituximab; Thyroid Function Tests; Treatment Outcome; Vincristine; Young Adult | 2015 |
CT-based versus FDG-PET/CT-based NCCN international prognostic index risk stratification in DLBCL.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
False-negative FDG-PET in histologically proven extensive large cell bone marrow involvement in diffuse large B-cell lymphoma.
Topics: Aged; Bone Marrow; Eosine Yellowish-(YS); False Negative Reactions; Fluorodeoxyglucose F18; Hematoxylin; Histocytochemistry; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Radiography | 2015 |
[¹⁸F-FDG PET/CT for predicting outcomes of diffuse large B-cell lymphoma: shall it be performed in the interim versus later phase of chemotherapy?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2015 |
(18)FDG PET/CT appearance in primary cutaneous diffuse large B-cell lymphoma, leg type.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Leg; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
Diffuse Large B-Cell Lymphoma Infiltrating Limb Bones With a Few Lymphadenopathy Revealed on Whole-Body 18F-FDG PET/CT.
Topics: Aged; Axilla; Bone Neoplasms; Fluorodeoxyglucose F18; Groin; Humans; Lower Extremity; Lymph Nodes; Lymphatic Diseases; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Upper Extremity | 2015 |
Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Salvage Therapy; Time Factors; Transplantation, Autologous | 2015 |
Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Rituximab | 2015 |
Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission.
Topics: Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Health Care Costs; Humans; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Markov Chains; Middle Aged; Models, Economic; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Quality-Adjusted Life Years; Radiopharmaceuticals; Remission Induction; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; Rituximab; Salvage Therapy; Vincristine; Young Adult | 2015 |
Primary bilateral diffuse large B-cell lymphoma of the adrenals.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
[The role of radiotherapy in chemoradiation treatment for nodal diffuse large B-cell non-Hodgkin lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Leukopenia; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Neutropenia; Positron-Emission Tomography; Radiation Pneumonitis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Thrombocytopenia; Treatment Outcome | 2015 |
Evidence-based reflection on the value of FDG-PET for interim and end-of-treatment response assessment in diffuse large B-cell lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2015 |
[Diagnostic value of three evaluation methods of ¹⁸F-FDG PET/CT in detecting bone marrow infiltration in patients with newly diagnosed diffuse large B-cell lymphoma].
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Use of temozolomide instead of cyclophosphamide in diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Dacarbazine; Drug Hypersensitivity; Drug Substitution; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Recurrence; Temozolomide; Treatment Outcome; Young Adult | 2016 |
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Rituximab; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2015 |
A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiotherapy; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Young Adult | 2016 |
Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2015 |
Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Canada; Cyclophosphamide; Denmark; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Ovary; Pleura; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2015 |
Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Vincristine | 2016 |
[Value of PET/CT after Chemotherapy for Evaluating Therapentic Efficacy of Patients with Diffuse Large B-cell Lymphoma].
Topics: Antineoplastic Agents; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
FDG PET/CT Findings in Primary Diffuse Large B-cell Lymphoma, Leg Type.
Topics: Fluorodeoxyglucose F18; Humans; Leg; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
[The prognosis value of early and interim ¹⁸F-FDG-PET/CT scans in patients with diffuse large B-cell lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Prognosis; Reproducibility of Results; Rituximab; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2015 |
Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Focally Increased FDG Activity in the Liver Related to Hydropic Degeneration.
Topics: Chemical and Drug Induced Liver Injury; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography.
Topics: Central Nervous System Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient.
Topics: Aftercare; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Asymptomatic Diseases; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Fractures, Spontaneous; Giant Cell Arteritis; Humans; Humeral Fractures; Incidental Findings; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Male; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Subclavian Steal Syndrome; Temporal Arteries; Vincristine | 2016 |
Prostate Lymphoma Complicated With Prostatorectal Fistula and Multifocal Infection After Chemotherapy.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Fistula; Sepsis; Tomography, X-Ray Computed | 2016 |
Prognostic value of negative interim 2-[¹⁸F]-fluoro-2-deoxy-d-glucose PET/CT in diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Reply to H.J.A. Adams and T.C. Kwee.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Radionuclide Imaging; Radiopharmaceuticals | 2016 |
Both Interim and End-of-Treatment 18F-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Scans Have Low Value in Diffuse Large B-Cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Radionuclide Imaging; Radiopharmaceuticals | 2016 |
FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma.
Topics: Abdominal Fat; Fat Necrosis; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Treatment Outcome | 2016 |
Predictive Significance of a New Prognostic Score for Patients With Diffuse Large B-Cell Lymphoma in the Interim-Positron Emission Tomography Findings.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2016 |
(89) Zr-rituximab PET/CT to detect neurolymphomatosis.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Marek Disease; Middle Aged; Phenotype; Positron Emission Tomography Computed Tomography; Rituximab | 2016 |
The Value of 18F-FDG PET/CT in Diagnostic Procedure of Intravascular Large B-Cell Lymphoma Presenting Fever of Unknown Origin and Pulmonary Hypertension as an Initial Manifestation.
Topics: Biopsy; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Hypertension, Pulmonary; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vascular Neoplasms | 2016 |
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Treatment Outcome; Tumor Burden; Young Adult | 2016 |
A unique subtype of diffuse large B-cell lymphoma primarily involving the bone marrow, spleen, and liver, defined by fluorodeoxyglucose-positron emission tomography combined with computed tomography.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Liver; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Spleen; Treatment Outcome; Whole Body Imaging | 2016 |
The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study.
Topics: Adult; Aged; Biopsy; Bone Marrow; Canada; Denmark; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis | 2016 |
Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score? Reply to Adams and Kwee.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2017 |
Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Disseminated Lymphoma Evolving into Neurolymphomatosis during Mid-cycle of Chemotherapy Detected by (18)F-FDG PET/CT.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Peripheral Nervous System Neoplasms; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Vincristine | 2015 |
Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Penile Neoplasms; Positron-Emission Tomography; Prednisone; Recurrence; Rituximab; Tomography, X-Ray Computed; Vincristine | 2016 |
Diffuse Large B-Cell Lymphoma Presenting with Bilateral Renal Masses and Hematuria: A Case Report.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Fluorodeoxyglucose F18; Hematuria; Humans; Image Enhancement; Immunohistochemistry; Kidney; Kidney Diseases; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2016 |
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2016 |
Interim18 F-FLUORO-2-deoxy-d-glucose positron emission tomography scan/computed tomography scan in diffuse large B cell lymphoma-as a prognostic tool.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2016 |
Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin's lymphoma. CCHE experience.
Topics: Adolescent; Burkitt Lymphoma; Cancer Care Facilities; Child; Child, Preschool; Egypt; Female; Fluorodeoxyglucose F18; Hospitals, Pediatric; Humans; Infant; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
(18)F-FDG hepatic superscan caused by a non-germinal center subtype of diffuse large B-cell lymphoma.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Biological correlation between glucose transporters, Ki-67 and 2-deoxy-2-[18F]-fluoro-D-glucose uptake in diffuse large B-cell lymphoma and natural killer/T-cell lymphoma.
Topics: Cell Line; Fluorodeoxyglucose F18; Glucose; Glucose Transport Proteins, Facilitative; Humans; Ki-67 Antigen; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Natural Killer T-Cells | 2016 |
Clinical significance of post-treatment
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neck; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Statistics as Topic; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2016 |
Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-Letter.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography | 2016 |
Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-Response.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography | 2016 |
Zosteriform Secondary Cutaneous Diffuse Large B-Cell Lymphoma on FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2016 |
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Splenic Neoplasms; Young Adult | 2017 |
FDG PET/CT response in diffuse large B-cell lymphoma: Reader variability and association with clinical outcome.
Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Young Adult | 2016 |
FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
Topics: Biomarkers; Clinical Studies as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis | 2016 |
Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prednisone; Proportional Hazards Models; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rituximab; Time Factors; Treatment Outcome; Tumor Burden; Vincristine; Young Adult | 2016 |
PET/CT Scanner and Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Analysis; Young Adult | 2017 |
The Association Between Liver and Tumor [
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Demography; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Function Tests; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Tumor Burden | 2017 |
Central Nervous System Involvement of Intravascular Large B-Cell Lymphoma on 18F-FDG PET/CT.
Topics: Central Nervous System; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
18F-FDG PET/CT Imaging of Epididymal Smooth Muscle Mass Mimicking Recurrent Lymphoma.
Topics: Aged, 80 and over; Diagnosis, Differential; Epididymis; Fluorodeoxyglucose F18; Hamartoma; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Muscle, Smooth; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
A linear lesion along the brachial plexus on FDG-PET in neurolymphomatosis.
Topics: Brachial Plexus; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Sural Nerve | 2008 |
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Rituximab; Whole Body Imaging | 2008 |
[Role of 18F-FDG PET in tumor grading and evaluating effectiveness of therapy in malignant lymphomas].
Topics: Adult; Aged; Female; Fibrosis; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Spiral Computed; Treatment Outcome | 2008 |
Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating 18fluorodeoxyglucose positron emission tomography to the International Workshop Criteria.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prospective Studies; Rituximab; Treatment Outcome; Vincristine | 2009 |
Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2009 |
The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2009 |
[Diagnostic value of FDG-PET in the detection of bone marrow involvement in patients with diffuse large B-cell lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Leukemic Infiltration; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Young Adult | 2008 |
A case of primary cutaneous diffuse large B-cell lymphoma, leg type monitored with fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Leg; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2009 |
Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Topics: Aged; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Humans; Immunohistochemistry; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged | 2009 |
Primary cardiac lymphoma evaluated with integration of PET/CT and contrast-enhanced CT.
Topics: Adult; Atrioventricular Block; Contrast Media; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Heart Septum; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Pleura; Positron-Emission Tomography; Radiopharmaceuticals; Syncope; Tomography, X-Ray Computed | 2009 |
Gallium scan-prompted skin biopsy revealed intravascular large B-cell lymphoma in a patient who presented with fever of unknown origin.
Topics: Adult; Biopsy; Fever of Unknown Origin; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Radiopharmaceuticals; Skin; Vascular Neoplasms; Whole Body Imaging | 2009 |
[Usefulness of FDG-PET/CT for the diagnosis of intravascular large B-cell lymphoma presenting with fever of unknown origin and renal dysfunction].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Renal Insufficiency; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vascular Neoplasms; Vindesine | 2009 |
18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
Topics: Adult; Aged; Biopsy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastric Mucosa; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Stomach Ulcer; Tomography, X-Ray Computed; Young Adult | 2010 |
[18F-FDG uptake of lymphoma lesions of various histological subtypes].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ki-67 Antigen; Lymphoma, B-Cell; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Unusual involvement of scalp and bilateral kidneys in an aggressive mediastinal diffuse large B cell lymphoma: documentation by FDG-PET imaging.
Topics: Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Scalp; Skin Neoplasms | 2009 |
Diffuse involvement of the heart and great vessels in primary cardiac lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Echocardiography; Fatal Outcome; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pneumonia; Positron-Emission Tomography; Prednisone; Rituximab; Tomography, X-Ray Computed; Vincristine | 2010 |
Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation--where do we stand?
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Time Factors; Treatment Outcome | 2009 |
Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Treatment Outcome | 2009 |
Positron emission tomography/computed tomography after immunocytochemical and clonal diagnosis of intraocular lymphoma with vitrectomy cell blocks.
Topics: Aged; Aged, 80 and over; Antigens, CD20; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin Heavy Chains; Ki-67 Antigen; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Radiopharmaceuticals; Vitrectomy | 2009 |
Interesting image. FDG-PET/CT in primary large B-cell lymphoma of the hard palate.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Jaw Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Palate, Hard; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy.
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Risk Factors; Tomography, X-Ray Computed | 2010 |
18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reports.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Registries; Treatment Outcome | 2010 |
Primary gastric diffuse large B-cell Lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scan.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hemoglobins; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Rituximab; Serum Albumin; Stomach Neoplasms; Survival Analysis; Vincristine; Young Adult | 2010 |
Using 18F-FDG positron emission tomography/computed tomography to judge benign or malignant colorectal hypermetabolic lesions.
Topics: Adenocarcinoma; Adenomatous Polyps; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Risk Factors; Rituximab; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2010 |
The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Blood Glucose; Cecal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Positron emission tomography combined with computed tomography as an integral component in evaluation of primary cardiac lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Echocardiography; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Syncope; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Intravascular lymphoma as an unusual cause of multifocal cerebral infarctions discovered on FDG-PET/CT.
Topics: Aged; Cerebral Infarction; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Neoplasms | 2010 |
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome; Young Adult | 2011 |
Fluorodeoxyglucose-PET/CT for diagnosis of intravascular large B-cell lymphoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Tomography, X-Ray Computed; Vascular Neoplasms | 2010 |
The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.
Topics: Antineoplastic Agents; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography | 2011 |
Can the interim fluorodeoxyglucose-positron emission tomography standardized uptake value be used to determine the need for residual mass biopsy after dose-dense immunochemotherapy for advanced diffuse large B-cell lymphoma?
Topics: Antineoplastic Agents; Biopsy; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colony-Stimulating Factors; Dexamethasone; Female; Fluorodeoxyglucose F18; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Radiopharmaceuticals; Thalidomide | 2011 |
Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study.
Topics: Adult; Aged; Antineoplastic Agents; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Statistics, Nonparametric; Time Factors; Tomography, X-Ray Computed; Young Adult | 2011 |
Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Palatine Tonsil; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Tonsillar Neoplasms; Vincristine | 2011 |
Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prognosis; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2011 |
A mass originating from chronic pyothorax in the pleural cavity.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Empyema, Pleural; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Immunochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Pleural Cavity; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Vincristine | 2011 |
No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: a PET/CT and DW-MRI study.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biomarkers; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lymphoma, Large B-Cell, Diffuse; Male; Meglumine; Middle Aged; Multimodal Imaging; Neoplasm Staging; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Spontaneous remission in localized diffuse large B-cell lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Regression, Spontaneous; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission, Spontaneous; Tomography, X-Ray Computed | 2011 |
Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Vincristine | 2012 |
Bilateral cutaneous diffuse large B-cell lymphoma on FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: staging with 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antigens, Neoplasm; Biopsy, Needle; Cell Division; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Ki-67 Antigen; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiography, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Primary gastric diffuse large B-cell lymphoma with orbital involvement: diagnostic usefulness of 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Biopsy; Drug Therapy; Endoscopy, Gastrointestinal; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Spectroscopy; Male; Orbit; Orbital Neoplasms; Positron-Emission Tomography; Salvage Therapy; Stomach Neoplasms; Treatment Outcome | 2011 |
Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reference Values; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2012 |
Histiocyte-rich xanthomatous pseudotumor mimicking relapse on positron emission tomography imaging in an adolescent with primary mediastinal diffuse large B-cell lymphoma.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Histiocytosis; Humans; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Xanthomatosis | 2012 |
Neurolymphomatosis: role of positron emission tomography in diagnosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Recurrence; Uterine Cervical Neoplasms | 2012 |
Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab.
Topics: Adult; Aged; Anthracyclines; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Young Adult | 2012 |
Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzopyrans; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Endometrium; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Remission Induction; Rituximab; Tomography, X-Ray Computed; Transplantation, Autologous; Vascular Neoplasms; Vincristine | 2011 |
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Young Adult | 2012 |
Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain; Capillaries; Cognition Disorders; Cyclophosphamide; Doxorubicin; False Negative Reactions; Female; Fever; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Paresis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tissue Distribution; Tomography, X-Ray Computed; Vincristine | 2012 |
[Positron emission tomography with 18F-FDG compared with proliferative activity of tumor cells in different subtypes of non-Hodgkin lymphoma].
Topics: Adult; Aged; Biomarkers, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Linear Models; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Rituximab; Treatment Failure; Vincristine; Young Adult | 2012 |
Primary bone lymphoma involving bilateral tibia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Menisci, Tibial; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Tibia; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2012 |
Value of 18FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience.
Topics: Aged; Conjunctiva; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Orbit; Positron-Emission Tomography; Radioisotopes; Retrospective Studies | 2012 |
The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Risk; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2012 |
Peripheral bone involvement of intravascular large B-cell lymphoma on 99mTc-MDP bone scan and 18F-FDG PET/CT.
Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
FDG-PET guided diagnosis of vaginal intravascular diffuse large B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capillaries; Cyclophosphamide; Fatal Outcome; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Paraproteins; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Vagina; Vascular Neoplasms; Vincristine | 2012 |
Posterior reversible encephalopathy syndrome (PRES) after granulocyte-colony stimulating factor (G-CSF) therapy: a report of 2 cases.
Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Neurotoxicity Syndromes; Positron-Emission Tomography; Young Adult | 2012 |
Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate.
Topics: Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Differentiation of newly diagnosed glioblastoma multiforme and intracranial diffuse large B-cell Lymphoma using (11)C-methionine and (18)F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methionine; Middle Aged; Positron-Emission Tomography; Quality Control; Retrospective Studies; Young Adult | 2012 |
18F-FDG PET/CT diagnosis of vagus nerve neurolymphomatosis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Multimodal Imaging; Neoplasms, Nerve Tissue; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Vagus Nerve Diseases | 2012 |
[Fever and persistent cough in a 65-year-old patient].
Topics: Aged; Cough; Fever; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Vascular Neoplasms | 2013 |
Frequent relapse and irradiation strategy in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Topics: Aged, 80 and over; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2013 |
18F-FDG uptake changes in liver and mediastinum during chemotherapy in patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Richter's syndrome: Utility of ¹⁸F-FDG PET/CT.
Topics: Aged; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Syndrome; Tomography, X-Ray Computed | 2013 |
[18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner.
Topics: Animals; Antibiotics, Antineoplastic; Caspase 3; Cell Proliferation; Dideoxynucleosides; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, SCID; Neoplasm Staging; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Transplantation, Heterologous | 2013 |
Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Prednisolone; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2013 |
Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan.
Topics: Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Pretherapy and posttherapy 18F-FDG PET/CT in isolated nasoseptal diffuse large B-cell lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Nasal Septum; Nose Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Huge testicular lymphoma on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography-computed tomography.
Topics: Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Testicular Neoplasms; Tomography, X-Ray Computed | 2013 |
Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Severity of Illness Index; Survival Analysis; Treatment Outcome; Young Adult | 2013 |
Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Decision Support Techniques; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Rituximab; Tomography, X-Ray Computed; Vincristine; Young Adult | 2013 |
Compensatory asymmetric hemidiaphragmatic uptake secondary to contralateral hemidiaphragmatic paresis.
Topics: Diaphragm; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Paresis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma.
Topics: Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Multicenter Studies as Topic; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Quality Control; Reference Standards; Tomography, X-Ray Computed | 2013 |
The role of FDG-PET scanning in assessing lymphoma in 2012.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
¹⁸F-fluorodeoxyglucose PET/CT findings of a solitary primary hepatic lymphoma: a case report.
Topics: Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Prognostic value of maximum standard uptake on pretreatment 18F-FDG PET/CT scan in newly diagnosed diffuse large B cell lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2012 |
Staging and monitoring in the treatment of lymphomas.
Topics: Biopsy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image-Guided Biopsy; Interdisciplinary Communication; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Neoplasm Staging; Neoplasm, Residual; Radiography; Radionuclide Imaging; Treatment Outcome | 2013 |
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[Prognostic value of (18)F-FDG PET/CT after first-line treatment in patients with diffuse large B cell lymphoma].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Treatment Outcome | 2012 |
Prognostic value of Waldeyer's ring involvement of diffuse large B-cell lymphoma treated with R-CHOP.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Radiography; Radiopharmaceuticals; Rituximab; Survival Rate; Tumor Burden; Vincristine | 2013 |
Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biopsy; Bone Marrow; Bone Marrow Cells; Brain; Cyclophosphamide; Doxorubicin; Femur; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Humerus; Ilium; Immunophenotyping; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Prednisone; Spine; Sternum; Tomography, Emission-Computed; Vascular Neoplasms; Vincristine | 2004 |
False-positive finding on 18F-FDG PET after chemotherapy for primary diffuse large B-cell lymphoma of the thyroid: a case report.
Topics: False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2004 |
Positron emission tomography in primary thyroid lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2004 |
Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Regression, Spontaneous; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
F-18 FDG PET and Ga-67 scintigraphy in a case of fever of unknown origin with underlying cutaneous diffuse large B-Cell lymphoma.
Topics: Citrates; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Skin Neoplasms | 2004 |
PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis.
Topics: Adult; Brachial Plexus; Fluorodeoxyglucose F18; Humans; Lumbosacral Plexus; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2005 |
Multiple nodular adenosis concurrent with primary breast lymphoma: pitfall in PET.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
FDG-PET imaging in cutaneous anaplastic large cell lymphoma.
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
PET/CT follow-up in nonossifying fibroma.
Topics: Child; Disease; Fibroma; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Radiopharmaceuticals; Remission, Spontaneous; Tibia; Tomography, X-Ray Computed | 2006 |
Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Treatment Outcome | 2006 |
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Iodine Radioisotopes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Retrospective Studies; Vincristine | 2006 |
18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Tomography, Emission-Computed; Vascular Neoplasms; Vincristine | 2007 |
Thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma concurrently diagnosed with a diffuse large B-cell lymphoma localized in the neck.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Nodule; Whole Body Imaging | 2007 |
Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Meningeal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stem Cell Transplantation; Treatment Outcome | 2007 |
Findings of fluorine-18-FDG PET in extranodal origin lymphoma--in three cases of diffuse large B cell type lymphoma.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Stomach Neoplasms | 2006 |
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Failure | 2007 |
Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Germinal Center; Humans; Immunophenotyping; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Proteins; Positron-Emission Tomography; Prognosis; Survival Rate | 2007 |
Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma.
Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Recurrence; Remission Induction; Treatment Failure; Valproic Acid | 2007 |
Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Mediastinal Diseases; Middle Aged; Mycobacterium tuberculosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis, Lymph Node; Uterine Cervical Neoplasms | 2007 |
FDG-PET detection of primary bone marrow large B-cell lymphoma in a patient with hairy cell leukemia.
Topics: Adult; Bone Marrow Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Leukemia, Hairy Cell; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.
Topics: Adolescent; Adult; Aged; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Case records of the Massachusetts General Hospital. Case 26-2007 - a 61-year-old man with recurrent fevers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Duodenum; Fever; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiography; Recurrence; Renal Insufficiency; Salvage Therapy; Vascular Neoplasms; Vincristine | 2007 |
FDG-PET scan and treatment planning for early stage Hodgkin lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted | 2007 |
Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
[The outcome of whole-body FDG-PET examination predicts the future of patients with diffuse large-cell lymphoma--editorial].
Topics: Fluorodeoxyglucose F18; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Whole Body Imaging | 2007 |
[The outcome of whole-body FDG-PET examination predicts the future of patients with diffuse large-cell lymphoma in the use of both intermediary staging and at the end of standard chemotherapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2007 |
Disseminated diffuse large B cell lymphoma of bone on PET scan.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Prednisolone; Radiography; Radiopharmaceuticals; Remission Induction; Rituximab; Spinal Neoplasms; Vincristine | 2008 |
Successful treatment of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy and FDG-PET scan.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Cyclophosphamide; Doxorubicin; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Rituximab; Translocation, Genetic; Vincristine | 2008 |
Evaluation of organ involvement in intravascular large B-cell lymphoma by 18F-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Kidney; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Skin | 2008 |
The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1991 |